{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "BERT_NER_0206",
      "provenance": [],
      "collapsed_sections": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "accelerator": "GPU"
  },
  "cells": [
    {
      "cell_type": "code",
      "metadata": {
        "id": "ukxkPSocGeiX",
        "colab_type": "code",
        "outputId": "8d49472f-4284-499d-a500-fc2972b82918",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 209
        }
      },
      "source": [
        "# wget을 활용해서 bert 모델 다운로드 가능\n",
        "import os\n",
        "!wget https://storage.googleapis.com/bert_models/2018_11_23/multi_cased_L-12_H-768_A-12.zip\n",
        "\n",
        "if \"bert\" not in os.listdir():\n",
        "  os.makedirs(\"bert\")\n",
        "else:\n",
        "  pass\n",
        "\n",
        "import zipfile\n",
        "import shutil\n",
        "         \n",
        "bert_zip = zipfile.ZipFile('multi_cased_L-12_H-768_A-12.zip')\n",
        "bert_zip.extractall('bert')\n",
        " \n",
        "bert_zip.close()\n",
        "\n",
        "def copytree(src, dst, symlinks=False, ignore=None):\n",
        "    for item in os.listdir(src):\n",
        "        s = os.path.join(src, item)\n",
        "        d = os.path.join(dst, item)\n",
        "        if os.path.isdir(s):\n",
        "            shutil.copytree(s, d, symlinks, ignore)\n",
        "        else:\n",
        "            shutil.copy2(s, d)\n",
        "\n",
        "copytree(\"bert/multi_cased_L-12_H-768_A-12\", \"bert\")"
      ],
      "execution_count": 88,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "--2020-02-06 08:05:09--  https://storage.googleapis.com/bert_models/2018_11_23/multi_cased_L-12_H-768_A-12.zip\n",
            "Resolving storage.googleapis.com (storage.googleapis.com)... 172.217.218.128, 2a00:1450:4013:c05::80\n",
            "Connecting to storage.googleapis.com (storage.googleapis.com)|172.217.218.128|:443... connected.\n",
            "HTTP request sent, awaiting response... 200 OK\n",
            "Length: 662903077 (632M) [application/zip]\n",
            "Saving to: ‘multi_cased_L-12_H-768_A-12.zip.1’\n",
            "\n",
            "multi_cased_L-12_H- 100%[===================>] 632.19M  79.5MB/s    in 7.5s    \n",
            "\n",
            "2020-02-06 08:05:17 (84.6 MB/s) - ‘multi_cased_L-12_H-768_A-12.zip.1’ saved [662903077/662903077]\n",
            "\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "eut0ua_Ovj1f",
        "colab_type": "code",
        "outputId": "a27d41d1-ad6f-422b-d012-5b72849c344e",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        }
      },
      "source": [
        "import pandas as pd\n",
        "import os\n",
        "from google.colab import drive\n",
        "drive.mount('/content/gdrive/')"
      ],
      "execution_count": 89,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Drive already mounted at /content/gdrive/; to attempt to forcibly remount, call drive.mount(\"/content/gdrive/\", force_remount=True).\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "AOY_AE8Rw1P_",
        "colab_type": "code",
        "outputId": "02b90f8b-45a0-4c6a-ae45-f86b02226b8d",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        }
      },
      "source": [
        "path='gdrive/My Drive/HUB/BC5CDR-disease'\n",
        "os.listdir(path)"
      ],
      "execution_count": 90,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['devel.tsv', 'test.tsv', 'train.tsv', 'train_dev.tsv']"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 90
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "CS_TF7_6PBQV",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "import tensorflow as tf\n",
        "\n",
        "import pandas as pd\n",
        "import numpy as np  \n",
        "import re\n",
        "import pickle\n",
        "\n",
        "import keras as keras\n",
        "from keras.models import load_model\n",
        "from keras import backend as K\n",
        "from keras import Input, Model\n",
        "from keras import optimizers\n",
        "\n",
        "import codecs\n",
        "from tqdm import tqdm\n",
        "import shutil"
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Xmp-zDEmPHMQ",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "import warnings\n",
        "import tensorflow as tf\n",
        "warnings.filterwarnings(action='ignore')\n",
        "os.environ['TF_CPP_MIN_LOG_LEVEL'] = '3' \n",
        "tf.logging.set_verbosity(tf.logging.ERROR)"
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "bO_OWLaexf-D",
        "colab_type": "code",
        "outputId": "86d97f1b-ea9f-4cce-d9db-3198a4b8b042",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 454
        }
      },
      "source": [
        "!pip install keras-bert\n",
        "!pip install keras-radam"
      ],
      "execution_count": 93,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: keras-bert in /usr/local/lib/python3.6/dist-packages (0.81.0)\n",
            "Requirement already satisfied: keras-transformer>=0.30.0 in /usr/local/lib/python3.6/dist-packages (from keras-bert) (0.32.0)\n",
            "Requirement already satisfied: Keras in /usr/local/lib/python3.6/dist-packages (from keras-bert) (2.2.5)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.6/dist-packages (from keras-bert) (1.17.5)\n",
            "Requirement already satisfied: keras-embed-sim>=0.7.0 in /usr/local/lib/python3.6/dist-packages (from keras-transformer>=0.30.0->keras-bert) (0.7.0)\n",
            "Requirement already satisfied: keras-multi-head>=0.22.0 in /usr/local/lib/python3.6/dist-packages (from keras-transformer>=0.30.0->keras-bert) (0.22.0)\n",
            "Requirement already satisfied: keras-position-wise-feed-forward>=0.5.0 in /usr/local/lib/python3.6/dist-packages (from keras-transformer>=0.30.0->keras-bert) (0.6.0)\n",
            "Requirement already satisfied: keras-pos-embd>=0.10.0 in /usr/local/lib/python3.6/dist-packages (from keras-transformer>=0.30.0->keras-bert) (0.11.0)\n",
            "Requirement already satisfied: keras-layer-normalization>=0.12.0 in /usr/local/lib/python3.6/dist-packages (from keras-transformer>=0.30.0->keras-bert) (0.14.0)\n",
            "Requirement already satisfied: keras-preprocessing>=1.1.0 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-bert) (1.1.0)\n",
            "Requirement already satisfied: pyyaml in /usr/local/lib/python3.6/dist-packages (from Keras->keras-bert) (3.13)\n",
            "Requirement already satisfied: scipy>=0.14 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-bert) (1.4.1)\n",
            "Requirement already satisfied: keras-applications>=1.0.8 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-bert) (1.0.8)\n",
            "Requirement already satisfied: h5py in /usr/local/lib/python3.6/dist-packages (from Keras->keras-bert) (2.8.0)\n",
            "Requirement already satisfied: six>=1.9.0 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-bert) (1.12.0)\n",
            "Requirement already satisfied: keras-self-attention==0.41.0 in /usr/local/lib/python3.6/dist-packages (from keras-multi-head>=0.22.0->keras-transformer>=0.30.0->keras-bert) (0.41.0)\n",
            "Requirement already satisfied: keras-radam in /usr/local/lib/python3.6/dist-packages (0.15.0)\n",
            "Requirement already satisfied: Keras in /usr/local/lib/python3.6/dist-packages (from keras-radam) (2.2.5)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.6/dist-packages (from keras-radam) (1.17.5)\n",
            "Requirement already satisfied: h5py in /usr/local/lib/python3.6/dist-packages (from Keras->keras-radam) (2.8.0)\n",
            "Requirement already satisfied: keras-preprocessing>=1.1.0 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-radam) (1.1.0)\n",
            "Requirement already satisfied: six>=1.9.0 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-radam) (1.12.0)\n",
            "Requirement already satisfied: keras-applications>=1.0.8 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-radam) (1.0.8)\n",
            "Requirement already satisfied: scipy>=0.14 in /usr/local/lib/python3.6/dist-packages (from Keras->keras-radam) (1.4.1)\n",
            "Requirement already satisfied: pyyaml in /usr/local/lib/python3.6/dist-packages (from Keras->keras-radam) (3.13)\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "PPh4L3HYPMDK",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "from keras_bert import load_trained_model_from_checkpoint, load_vocabulary\n",
        "from keras_bert import Tokenizer\n",
        "from keras_bert import AdamWarmup, calc_train_steps\n",
        "\n",
        "from keras_radam import RAdam"
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "3v_GH7jhwGTR",
        "colab_type": "code",
        "outputId": "1db70c64-e5d6-428b-b314-5a81c7f5db31",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        }
      },
      "source": [
        "#tsv 파일 읽어오기 -> 마지막 문장 부분 읽어오는데 문제 발생 -> 아래 코드 사용\n",
        "#df_en=pd.read_csv(path+\"/train.tsv\",delimiter='\\t',engine='python', error_bad_lines=False) "
      ],
      "execution_count": 0,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Skipping line 47788: unexpected end of data\n"
          ],
          "name": "stderr"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "rUPH8DbESTwL",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "import csv\n",
        "df_en=pd.read_table(path+\"/train.tsv\",delimiter='\\t',quoting=csv.QUOTE_NONE)"
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "pgCVphZDRNQr",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "def _read_data(input_file):\n",
        "  with open(input_file) as f:\n",
        "    lines = []\n",
        "    words = []\n",
        "    labels = []\n",
        "    for line in f:\n",
        "      contends = line.strip()\n",
        "      if len(contends) == 0:\n",
        "        assert len(words) == len(labels)\n",
        "        if len(words) >30:\n",
        "          while len(words) > 30:\n",
        "            tlabel = labels[:30]\n",
        "            for tidx in range(len(tlabel)):\n",
        "              if tlabel.pop() == 'O':\n",
        "                break\n",
        "            l = ' '.join([label for label in labels[:len(tlabel)+1] if len(label) > 0])\n",
        "            w = ' '.join([word for word in words[:len(tlabel)+1] if len(word) > 0])\n",
        "            lines.append([l,w])\n",
        "            words = words[len(tlabel)+1:]\n",
        "            labels = labels[len(tlabel)+1:]\n",
        "        if len(words) == 0:\n",
        "          continue\n",
        "        l = ' '.join([label for label in labels if len(label) > 0])\n",
        "        w = ' '.join([word for word in words if len(word) > 0])\n",
        "        lines.append([l, w])\n",
        "        words = []\n",
        "        labels = []\n",
        "        continue\n",
        "      word = line.strip().split()[0]\n",
        "      label = line.strip().split()[-1]\n",
        "      words.append(word)\n",
        "      labels.append(label)\n",
        "    return lines        "
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "UQErIbOCflI7",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "#test=_read_data(path+\"/train.tsv\")\n",
        "#for i in test:\n",
        "#  want_sen=i[0]\n",
        "#  want=want_sen.split(\" \")\n",
        "#  print(len(want))"
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "bfkbfrHLUQWb",
        "colab_type": "code",
        "outputId": "44d7c717-f5c4-420b-9b0a-9063f67dbfbd",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        }
      },
      "source": [
        "_read_data(path+\"/train.tsv\")"
      ],
      "execution_count": 97,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[['O O O B I O B I I I O O O O O O O O O O O',\n",
              "  \"Selegiline - induced postural hypotension in Parkinson ' s disease : a longitudinal study on the effects of drug withdrawal .\"],\n",
              " ['O O O O O B I I I O O O O O O O O O O O O O B I I I O B O O',\n",
              "  \"OBJECTIVES : The United Kingdom Parkinson ' s Disease Research Group ( UKPDRG ) trial found an increased mortality in patients with Parkinson ' s disease ( PD ) randomized\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'to receive 10 mg selegiline per day and L - dopa compared with those taking L - dopa alone .'],\n",
              " ['O O O O O O O O O O O O O O O O B I I O O O O O O O O',\n",
              "  'Recently , we found that therapy with selegiline and L - dopa was associated with selective systolic orthostatic hypotension which was abolished by withdrawal of selegiline .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'This unwanted effect on postural blood pressure was not the result of underlying autonomic failure .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The aims of this study were to confirm our previous findings in a separate cohort of patients and to determine the time course of the cardiovascular consequences of stopping selegiline'],\n",
              " ['O O O O O O O O O O O O O O O O B I O',\n",
              "  'in the expectation that this might shed light on the mechanisms by which the drug causes orthostatic hypotension .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O O',\n",
              "  'METHODS : The cardiovascular responses to standing and head - up tilt were studied repeatedly in PD patients receiving selegiline and as the drug was withdrawn .'],\n",
              " ['O O O O O O O B I I O O O O O O O B O O O O O O O O O O O O',\n",
              "  'RESULTS : Head - up tilt caused systolic orthostatic hypotension which was marked in six of 20 PD patients on selegiline , one of whom lost consciousness with unrecordable blood'],\n",
              " ['O O', 'pressures .'],\n",
              " ['O O O O B I O O O O',\n",
              "  'A lesser degree of orthostatic hypotension occurred with standing .'],\n",
              " ['B I O O O O O O O O O O O O O O O O O O O',\n",
              "  'Orthostatic hypotension was ameliorated 4 days after withdrawal of selegiline and totally abolished 7 days after discontinuation of the drug .'],\n",
              " ['O O O O B I I I I I I I O O O O O O O O O',\n",
              "  'Stopping selegiline also significantly reduced the supine systolic and diastolic blood pressures consistent with a previously undescribed supine pressor action .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'CONCLUSION : This study confirms our previous finding that selegiline in combination with L - dopa is associated with selective orthostatic hypotension .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The possibilities that these cardiovascular findings might be the result of non - selective inhibition of monoamine oxidase or of amphetamine and metamphetamine are discussed .'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'Further studies on effects of irrigation solutions on rat bladders .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Further studies on the effects of certain irrigating fluids on the rat bladder for 18 hours are reported .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'The results have shown that the degradation product p - choloroaniline is not a significant factor in chlorhexidine - digluconate associated erosive cystitis .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O',\n",
              "  'A high percentage of kanamycin - colistin and povidone - iodine irrigations were associated with erosive cystitis and suggested a possible complication with human usage .'],\n",
              " ['O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O',\n",
              "  'Picloxydine irrigations appeared to have a lower incidence of erosive cystitis but further studies would have to be performed before it could be recommended for use in urological procedures .'],\n",
              " ['O O O O O O O B O O O O B I O',\n",
              "  'Effects of tetrandrine and fangchinoline on experimental thrombosis in mice and human platelet aggregation .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Tetrandrine ( TET ) and fangchinoline ( FAN ) are two naturally occurring analogues with a bisbenzylisoquinoline structure .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O O O O',\n",
              "  'The present study was undertaken to investigate the effects of TET and FAN on the experimental thrombosis induced by collagen plus epinephrine ( EP ) in mice , and'],\n",
              " ['B I O B I O O O', 'platelet aggregation and blood coagulation in vitro .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In the in vivo study , the administration ( 50 mg / kg , i . p . ) of TET and FAN in mice showed the inhibition of'],\n",
              " ['B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'thrombosis by 55 % and 35 % , respectively , while acetylsalicylic acid ( ASA , 50 mg / kg , i . p . ) , a positive control'],\n",
              " ['O O O O O O O', ', showed only 30 % inhibition .'],\n",
              " ['O O O O B I O O O O O O O O O O O O O O O O O',\n",
              "  'In the vitro human platelet aggregations induced by the agonists used in tests , TET and FAN showed the inhibitions dose dependently .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In addition , neither TET nor FAN showed any anticoagulation activities in the measurement of the activated partial thromboplastin time ( APTT ) , prothrombin time ( PT ) and'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'thrombin time ( TT ) using human - citrated plasma .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'These results suggest that antithrombosis of TET and FAN in mice may be mainly related to the antiplatelet aggregation activities .'],\n",
              " ['B O O O O O O O O O O',\n",
              "  'Angioedema due to ACE inhibitors : common and inadequately diagnosed .'],\n",
              " ['O O O O B O O O O O O O O O O O O O O O O O O O',\n",
              "  'The estimated incidence of angioedema during angiotensin - converting enzyme ( ACE ) inhibitor treatment is between 1 and 7 per thousand patients .'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  'This potentially serious adverse effect is often preceded by minor manifestations that may serve as a warning .'],\n",
              " ['O O O B I O O O O B O O O O O O O O O',\n",
              "  'Cocaine - induced mood disorder : prevalence rates and psychiatric symptoms in an outpatient cocaine - dependent sample .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'This paper attempts to examine and compare prevalence rates and symptom patterns of DSM substance - induced and other mood disorders .'],\n",
              " ['O O O O O O O O O B I O B O O O B I O O O B I O O O O O B O',\n",
              "  '243 cocaine - dependent outpatients with cocaine - induced mood disorder ( CIMD ) , other mood disorders , or no mood disorder were compared on measures of psychiatric symptoms'],\n",
              " ['O', '.'],\n",
              " ['O O O O B O O O O O O',\n",
              "  'The prevalence rate for CIMD was 12 % at baseline .'],\n",
              " ['O O O O O O O O B O O O O O O O O B I O',\n",
              "  'Introduction of the DSM - IV diagnosis of CIMD did not substantially affect rates of the other depressive disorders .'],\n",
              " ['O O B O O O O O O O O O O O O B I O',\n",
              "  'Patients with CIMD had symptom severity levels between those of patients with and without a mood disorder .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O O O O',\n",
              "  'These findings suggest some validity for the new DSM - IV diagnosis of CIMD , but also suggest that it requires further specification and replication .'],\n",
              " ['O O O O O O O O B I O O O',\n",
              "  'Effect of fucoidan treatment on collagenase - induced intracerebral hemorrhage in rats .'],\n",
              " ['O O O O O O O O O B I O B I O',\n",
              "  'Inflammatory cells are postulated to mediate some of the brain damage following ischemic stroke .'],\n",
              " ['B I O O O O B O B I O',\n",
              "  'Intracerebral hemorrhage is associated with more inflammation than ischemic stroke .'],\n",
              " ['O O O O O O O O O O O O O O B I O O O O O O B I O O O O O O',\n",
              "  'We tested the sulfated polysaccharide fucoidan , which has been reported to reduce inflammatory brain damage , in a rat model of intracerebral hemorrhage induced by injection of bacterial collagenase'],\n",
              " ['O O O O O', 'into the caudate nucleus .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Rats were treated with seven day intravenous infusion of fucoidan ( 30 micrograms h - 1 ) or vehicle .'],\n",
              " ['O B O O O O O O O O O',\n",
              "  'The hematoma was assessed in vivo by magnetic resonance imaging .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'Motor behavior , passive avoidance , and skilled forelimb function were tested repeatedly for six weeks .'],\n",
              " ['O O O O O O O B I I O B O O O B O O O O O O B O O O O O B O',\n",
              "  'Fucoidan - treated rats exhibited evidence of impaired blood clotting and hemodilution , had larger hematomas , and tended to have less inflammation in the vicinity of the hematoma after'],\n",
              " ['O O O', 'three days .'],\n",
              " ['O O O O O O O O O O O O O O B O O O O O O O O O O',\n",
              "  'They showed significantly more rapid improvement of motor function in the first week following hemorrhage and better memory retention in the passive avoidance test .'],\n",
              " ['O B I I O O B I O O O O O O B O O O O O O O O',\n",
              "  'Acute white matter edema and eventual neuronal loss in the striatum adjacent to the hematoma did not differ between the two groups .'],\n",
              " ['O O O O O O O O O O O O O O B I O',\n",
              "  'Investigation of more specific anti - inflammatory agents and hemodiluting agents are warranted in intracerebral hemorrhage .'],\n",
              " ['O O O O O O', 'Recurarization in the recovery room .'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'A case of recurarization in the recovery room is reported .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Accumulation of atracurium in the intravenous line led to recurarization after flushing the line in the recovery room .'],\n",
              " ['O B I O O B O B O O',\n",
              "  'A respiratory arrest with severe desaturation and bradycardia occurred .'],\n",
              " ['O O O O O O O O O O B I O O O O O O O O O O O O O O O O',\n",
              "  'Circumstances leading to this event and the mechanisms enabling a neuromuscular blockade to occur , following the administration of a small dose of relaxant , are discussed .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The haemodynamic effects of propofol in combination with ephedrine in elderly patients ( ASA groups 3 and 4 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'The marked vasodilator and negative inotropic effects of propofol are disadvantages in frail elderly patients .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B O O',\n",
              "  'We investigated the safety and efficacy of adding different doses of ephedrine to propofol in order to obtund the hypotensive response .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The haemodynamic effects of adding 15 , 20 or 25 mg of ephedrine to 200 mg of propofol were compared to control in 40 ASA 3 / 4 patients over'],\n",
              " ['O O O O O O O O O', '60 years presenting for genito - urinary surgery .'],\n",
              " ['O O O O O O O O O O O O O O O B O O O O O O O O O O O',\n",
              "  'The addition of ephedrine to propofol appears to be an effective method of obtunding the hypotensive response to propofol at all doses used in this study .'],\n",
              " ['O O O B O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'However , marked tachycardia associated with the use of ephedrine in combination with propofol occurred in the majority of patients , occasionally reaching high levels in individual patients .'],\n",
              " ['O O O O O O B O B I O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Due to the risk of this tachycardia inducing myocardial ischemia , we would not recommend the use in elderly patients of any of the ephedrine / propofol / mixtures studied'],\n",
              " ['O', '.'],\n",
              " ['O O O O B I I I O O O O O O O O O O O O O',\n",
              "  'Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin .'],\n",
              " ['O O O O', 'Oncopaz Cooperative Group .'],\n",
              " ['O O O O O O B I I I O B O O O O O O O O O O O O O O O B O O',\n",
              "  'BACKGROUND : Although the prevalence of nonsmall cell lung carcinoma ( NSCLC ) is high among elderly patients , few data are available regarding the efficacy and toxicity of chemotherapy'],\n",
              " ['O O O O O O', 'in this group of patients .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Recent reports indicate that single agent therapy with vinorelbine ( VNB ) or gemcitabine ( GEM ) may obtain a response rate of 20 - 30 % in elderly patients'],\n",
              " ['O O O B O O O O O O O O O',\n",
              "  ', with acceptable toxicity and improvement in symptoms and quality of life .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O O B O O O O O O O O O',\n",
              "  'In the current study the efficacy and toxicity of the combination of GEM and VNB in elderly patients with advanced NSCLC or those with some contraindication to receiving cisplatin were'],\n",
              " ['O O', 'assessed .'],\n",
              " ['O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : Forty - nine patients with advanced NSCLC were included , 38 of whom were age > / = 70 years and 11 were age < 70 years but'],\n",
              " ['O O O O O O O O', 'who had some contraindication to receiving cisplatin .'],\n",
              " ['O O O O O O O B O',\n",
              "  'All patients were evaluable for response and toxicity .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Treatment was comprised of VNB , 25 mg / m ( 2 ) , plus GEM , 1000 mg / m ( 2 ) , both on Days 1 ,'],\n",
              " ['O O O O O O O O', '8 , and 15 every 28 days .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'Patients received a minimum of three courses unless progressive disease was detected .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'RESULTS : One hundred sixty - five courses were administered , with a median of 3 .'],\n",
              " ['O O O O O', '6 courses per patient .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'The overall response rate was 26 % ( 95 % confidence interval , 15 - 41 % ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Two patients attained a complete response ( 4 % ) and 11 patients ( 22 % ) achieved a partial response .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Eastern Cooperative Oncology Group performance status improved in 35 % of those patients with an initial value > 0 , whereas relief of at least 1 symptom without worsening of'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'other symptoms was noted in 27 patients ( 55 % ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'The median time to progression was 16 weeks and the 1 - year survival rate was 33 % .'],\n",
              " ['B O O O', 'Toxicity was mild .'],\n",
              " ['O O O O O O O O O O O O O O B O O O O O O O O O O O O B O O',\n",
              "  'Six patients ( 12 % ) had World Health Organization Grade 3 - 4 neutropenia , 2 patients ( 4 % ) had Grade 3 - 4 thrombocytopenia , and'],\n",
              " ['O O O O O O O O O B O', '2 patients ( 4 % ) had Grade 3 neurotoxicity .'],\n",
              " ['O O O O B O O O O O O B O',\n",
              "  'Three patients with severe neutropenia ( 6 % ) died of sepsis .'],\n",
              " ['O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O',\n",
              "  'The median age of those patients developing Grade 3 - 4 neutropenia was significantly higher than that of the remaining patients ( 75 years vs . 72 years ; P'],\n",
              " ['O O O O O O', '= 0 . 047 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'CONCLUSIONS : The combination of GEM and VNB is moderately active and well tolerated except in patients age > / = 75 years .'],\n",
              " ['O O O O O O O O B O',\n",
              "  'This age group had an increased risk of myelosuppression .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'Therefore the prophylactic use of granulocyte - colony stimulating factor should be considered with this treatment .'],\n",
              " ['O O O O O O O O B O O O O O O O B O',\n",
              "  'New chemotherapy combinations with higher activity and lower toxicity are needed for elderly patients with advanced NSCLC .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'A selective dopamine D4 receptor antagonist , NRA0160 : a preclinical neuropharmacological profile .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'NRA0160 , 5 - [ 2 - ( 4 - ( 3 - fluorobenzylidene ) piperidin - 1 - yl ) ethyl ] - 4 - ( 4 - fluorophenyl'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  ') thiazole - 2 - carboxamide , has a high affinity for human cloned dopamine D4 . 2 , D4 . 4 and D4 . 7 receptors , with Ki'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'values of 0 . 5 , 0 . 9 and 2 . 7 nM , respectively .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'NRA0160 is over 20 , 000fold more potent at the dopamine D4 . 2 receptor compared with the human cloned dopamine D2L receptor .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'NRA0160 has negligible affinity for the human cloned dopamine D3 receptor ( Ki = 39 nM ) , rat serotonin ( 5 - HT ) 2A receptors ( Ki ='],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  '180 nM ) and rat alpha1 adrenoceptor ( Ki = 237 nM ) .'],\n",
              " ['O O O O O B O O O O O O O O O',\n",
              "  'NRA0160 and clozapine antagonized locomotor hyperactivity induced by methamphetamine ( MAP ) in mice .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'NRA0160 and clozapine antagonized MAP - induced stereotyped behavior in mice , although their effects did not exceed 50 % inhibition , even at the highest dose given .'],\n",
              " ['O O O O O B O O O O O O O O O O O O O O O O O O O',\n",
              "  'NRA0160 and clozapine significantly induced catalepsy in rats , although their effects did not exceed 50 % induction even at the highest dose given .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'NRA0160 and clozapine significantly reversed the disruption of prepulse inhibition ( PPI ) in rats produced by apomorphine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'NRA0160 and clozapine significantly shortened the phencyclidine ( PCP ) - induced prolonged swimming latency in rats in a water maze task .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'These findings suggest that NRA0160 may have unique antipsychotic activities without the liability of motor side effects typical of classical antipsychotics .'],\n",
              " ['O O O B I O O O O O O O O',\n",
              "  'Warfarin - induced artery calcification is accelerated by growth and vitamin D .'],\n",
              " ['O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O',\n",
              "  'The present studies demonstrate that growth and vitamin D treatment enhance the extent of artery calcification in rats given sufficient doses of Warfarin to inhibit gamma - carboxylation of matrix'],\n",
              " ['O O O O B O O O O O O O O O O O O O O O O',\n",
              "  'Gla protein , a calcification inhibitor known to be expressed by smooth muscle cells and macrophages in the artery wall .'],\n",
              " ['O O O O O O O O O O O O O O B I O O O O O O',\n",
              "  'The first series of experiments examined the influence of age and growth status on artery calcification in Warfarin - treated rats .'],\n",
              " ['O O O O O O O O O B I I I O O O O O O O O O O O O B O O O O',\n",
              "  'Treatment for 2 weeks with Warfarin caused massive focal calcification of the artery media in 20 - day - old rats and less extensive focal calcification in 42 - day'],\n",
              " ['O O O O', '- old rats .'],\n",
              " ['O O O O B I O O O O O O O O O O O O O O O O O O O',\n",
              "  'In contrast , no artery calcification could be detected in 10 - month - old adult rats even after 4 weeks of Warfarin treatment .'],\n",
              " ['O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O',\n",
              "  'To directly examine the importance of growth to Warfarin - induced artery calcification in animals of the same age , 20 - day - old rats were fed for 2'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'weeks either an ad libitum diet or a 6 - g / d restricted diet that maintains weight but prevents growth .'],\n",
              " ['O O O O O O O O O O O B I I I O O O O O O O O O O O B I O O',\n",
              "  'Concurrent treatment of both dietary groups with Warfarin produced massive focal calcification of the artery media in the ad libitum - fed rats but no detectable artery calcification in the'],\n",
              " ['O O O O O O O O O', 'restricted - diet , growth - inhibited group .'],\n",
              " ['O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Although the explanation for the association between artery calcification and growth status cannot be determined from the present study , there was a relationship between higher serum phosphate and susceptibility'],\n",
              " ['O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'to artery calcification , with 30 % higher levels of serum phosphate in young , ad libitum - fed rats compared with either of the groups that was resistant to'],\n",
              " ['O O O B I O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Warfarin - induced artery calcification , ie , the 10 - month - old rats and the restricted - diet , growth - inhibited young rats .'],\n",
              " ['O O O O O O O O O O B I O O O O O O O O O',\n",
              "  'This observation suggests that increased susceptibility to Warfarin - induced artery calcification could be related to higher serum phosphate levels .'],\n",
              " ['O O O O O O O O O O O O O O O B I O',\n",
              "  'The second set of experiments examined the possible synergy between vitamin D and Warfarin in artery calcification .'],\n",
              " ['O O O O O O O O O B I I I O O O O O O O O O O',\n",
              "  'High doses of vitamin D are known to cause calcification of the artery media in as little as 3 to 4 days .'],\n",
              " ['O O O O O O O O O O O O O B I I I O O O O O O O O O O O O O',\n",
              "  'High doses of the vitamin K antagonist Warfarin are also known to cause calcification of the artery media , but at treatment times of 2 weeks or longer yet not'],\n",
              " ['O O O O', 'at 1 week .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O',\n",
              "  'In the current study , we investigated the synergy between these 2 treatments and found that concurrent Warfarin administration dramatically increased the extent of calcification in the media of vitamin'],\n",
              " ['O O O O O O O O O O', 'D - treated rats at 3 and 4 days .'],\n",
              " ['O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'There was a close parallel between the effect of vitamin D dose on artery calcification and the effect of vitamin D dose on the elevation of serum calcium , which'],\n",
              " ['O O O O O O B I O O O O O O O',\n",
              "  'suggests that vitamin D may induce artery calcification through its effect on serum calcium .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Because Warfarin treatment had no effect on the elevation in serum calcium produced by vitamin D , the synergy between Warfarin and vitamin D is probably best explained by the'],\n",
              " ['O O O O O O O O O O O O B O O',\n",
              "  'hypothesis that Warfarin inhibits the activity of matrix Gla protein as a calcification inhibitor .'],\n",
              " ['O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O',\n",
              "  'High levels of matrix Gla protein are found at sites of artery calcification in rats treated with vitamin D plus Warfarin , and chemical analysis showed that the protein that'],\n",
              " ['O O O O O O O O', 'accumulated was indeed not gamma - carboxylated .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O',\n",
              "  'These observations indicate that although the gamma - carboxyglutamate residues of matrix Gla protein are apparently required for its function as a calcification inhibitor , they are not required for'],\n",
              " ['O O O B O O', 'its accumulation at calcification sites .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'Test conditions influence the response to a drug challenge in rodents .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'These studies were conducted to examine the differential response to a drug challenge under varied experimental test conditions routinely employed to study drug - induced behavioral and neurophysiological responses in'],\n",
              " ['O O', 'rodents .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O',\n",
              "  'Apomorphine , a nonselective dopamine agonist , was selected due to its biphasic behavioral effects , its ability to induce hypothermia , and to produce distinct changes to dopamine turnover'],\n",
              " ['O O O O O', 'in the rodent brain .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'From such experiments there is evidence that characterization and detection of apomorphine - induced activity in rodents critically depends upon the test conditions employed .'],\n",
              " ['O O O O O O O O B O O O O O O O O O O O O',\n",
              "  'In rats , detection of apomorphine - induced hyperactivity was facilitated by a period of acclimatization to the test conditions .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O',\n",
              "  'Moreover , test conditions can impact upon other physiological responses to apomorphine such as drug - induced hypothermia .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In mice , apomorphine produced qualitatively different responses under novel conditions when compared to those behaviors elicited in the home test cage .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Drug - induced gross activity counts were increased in the novel exploratory box only , while measures of stereotypic behavior were similar in both .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'By contrast , apomorphine - induced locomotion was more prominent in the novel exploratory box .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Dopamine turnover ratios ( DOPAC : DA and HVA : DA ) were found to be lower in those animals exposed to the exploratory box when compared to their home'],\n",
              " ['O O O', 'cage counterparts .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'However , apomorphine - induced reductions in striatal dopamine turnover were detected in both novel and home cage environments .'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  'The implications of these findings are discussed with particular emphasis upon conducting psychopharmacological challenge tests in rodents .'],\n",
              " ['B O O O O O O O O O O O O O O',\n",
              "  'Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure .'],\n",
              " ['O O O O O O O O O O O O O O O B I O O O O O O O O O O B I O',\n",
              "  'Tamoxifen ( TAM ) , the antiestrogenic drug most widely prescribed in the chemotherapy of breast cancer , induces changes in normal discoid shape of erythrocytes and hemolytic anemia .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O',\n",
              "  'This work evaluates the effects of TAM on isolated human erythrocytes , attempting to identify the underlying mechanisms on TAM - induced hemolytic anemia and the involvement of biomembranes in'],\n",
              " ['O O O O O', 'its cytostatic action mechanisms .'],\n",
              " ['O O B O O O O O O O O',\n",
              "  'TAM induces hemolysis of erythrocytes as a function of concentration .'],\n",
              " ['O O O B O O O O O O O O O O O O O O B O O O O O',\n",
              "  'The extension of hemolysis is variable with erythrocyte samples , but 12 . 5 microM TAM induces total hemolysis of all tested suspensions .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'Despite inducing extensive erythrocyte lysis , TAM does not shift the osmotic fragility curves of erythrocytes .'],\n",
              " ['O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The hemolytic effect of TAM is prevented by low concentrations of alpha - tocopherol ( alpha - T ) and alpha - tocopherol acetate ( alpha - TAc ) ('],\n",
              " ['O O O O O O O O O B O O O O O O O O',\n",
              "  'inactivated functional hydroxyl ) indicating that TAM - induced hemolysis is not related to oxidative membrane damage .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'This was further evidenced by absence of oxygen consumption and hemoglobin oxidation both determined in parallel with TAM - induced hemolysis .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Furthermore , it was observed that TAM inhibits the peroxidation of human erythrocytes induced by AAPH , thus ruling out TAM - induced cell oxidative stress .'],\n",
              " ['B O O O O O O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'Hemolysis caused by TAM was not preceded by the leakage of K ( + ) from the cells , also excluding a colloid - osmotic type mechanism of hemolysis ,'],\n",
              " ['O O O O O O O O O',\n",
              "  'according to the effects on osmotic fragility curves .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'However , TAM induces release of peripheral proteins of membrane - cytoskeleton and cytosol proteins essentially bound to band 3 .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Either alpha - T or alpha - TAc increases membrane packing and prevents TAM partition into model membranes .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'These effects suggest that the protection from hemolysis by tocopherols is related to a decreased TAM incorporation in condensed membranes and the structural damage of the erythrocyte membrane is consequently'],\n",
              " ['O O', 'avoided .'],\n",
              " ['O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Therefore , TAM - induced hemolysis results from a structural perturbation of red cell membrane , leading to changes in the framework of the erythrocyte membrane and its cytoskeleton caused'],\n",
              " ['O O O O O O O O', 'by its high partition in the membrane .'],\n",
              " ['O O O O O O O O O O O O O O O O O B I O',\n",
              "  'These defects explain the abnormal erythrocyte shape and decreased mechanical stability promoted by TAM , resulting in hemolytic anemia .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Additionally , since membrane leakage is a final stage of cytotoxicity , the disruption of the structural characteristics of biomembranes by TAM may contribute to the multiple mechanisms of its'],\n",
              " ['O O O', 'anticancer action .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'Changes of sodium and ATP affinities of the cardiac ( Na , K ) - ATPase during and after nitric oxide deficient hypertension .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'In the cardiovascular system , NO is involved in the regulation of a variety of functions .'],\n",
              " ['O O O O O O B O',\n",
              "  'Inhibition of NO synthesis induces sustained hypertension .'],\n",
              " ['O O O O B O O O O O O O O O O O O',\n",
              "  'In several models of hypertension , elevation of intracellular sodium level was documented in cardiac tissue .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'To assess the molecular basis of disturbances in transmembraneous transport of Na + , we studied the response of cardiac ( Na , K ) - ATPase to NO -'],\n",
              " ['O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'deficient hypertension induced in rats by NO - synthase inhibition with 40 mg / kg / day N ( G ) - nitro - L - arginine methyl ester ('],\n",
              " ['O O O O O O O O O', 'L - NAME ) for 4 four weeks .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'After 4 - week administration of L - NAME , the systolic blood pressure ( SBP ) increased by 36 % .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'Two weeks after terminating the treatment , the SBP recovered to control value .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'When activating the ( Na , K ) - ATPase with its substrate ATP , no changes in Km and Vmax values were observed in NO - deficient rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'During activation with Na + , the Vmax remained unchanged , however the K ( Na ) increased by 50 % , indicating a profound decrease in the affinity of'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'the Na + - binding site in NO - deficient rats .'],\n",
              " ['O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'After recovery from hypertension , the activity of ( Na , K ) - ATPase increased , due to higher affinity of the ATP - binding site , as revealed'],\n",
              " ['O O O O O O O O', 'from the lowered Km value for ATP .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'The K ( Na ) value for Na + returned to control value .'],\n",
              " ['O O O O O O O O B O O B O O O O O O O O O O O O O O O O O O',\n",
              "  'Inhibition of NO - synthase induced a reversible hypertension accompanied by depressed Na + - extrusion from cardiac cells as a consequence of deteriorated Na + - binding properties of'],\n",
              " ['O O O O O O O O O', 'the ( Na , K ) - ATPase .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'After recovery of blood pressure to control values , the extrusion of Na + from cardiac cells was normalized , as revealed by restoration of the ( Na , K'],\n",
              " ['O O O O O', ') - ATPase activity .'],\n",
              " ['O O O O O O O O O O O O B O O O O',\n",
              "  'Effects of long - term pretreatment with isoproterenol on bromocriptine - induced tachycardia in conscious rats .'],\n",
              " ['O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'It has been shown that bromocriptine - induced tachycardia , which persisted after adrenalectomy , is ( i ) mediated by central dopamine D2 receptor activation and ( ii )'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'reduced by 5 - day isoproterenol pretreatment , supporting therefore the hypothesis that this effect is dependent on sympathetic outflow to the heart .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O',\n",
              "  'This study was conducted to examine whether prolonged pretreatment with isoproterenol could abolish bromocriptine - induced tachycardia in conscious rats .'],\n",
              " ['O O O O O O B I O O O O O O O O O',\n",
              "  'Isoproterenol pretreatment for 15 days caused cardiac hypertrophy without affecting baseline blood pressure and heart rate .'],\n",
              " ['O O O O O O O O O O O O O O B O B O',\n",
              "  'In control rats , intravenous bromocriptine ( 150 microg / kg ) induced significant hypotension and tachycardia .'],\n",
              " ['O O O B O O O O O O O B O O O O B O O O O O O O O O O O O O',\n",
              "  'Bromocriptine - induced hypotension was unaffected by isoproterenol pretreatment , while tachycardia was reversed to significant bradycardia , an effect that was partly reduced by i . v . domperidone'],\n",
              " ['O O O O O O O O O', '( 0 . 5 mg / kg ) .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'Neither cardiac vagal nor sympathetic tone was altered by isoproterenol pretreatment .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In isolated perfused heart preparations from isoproterenol - pretreated rats , the isoproterenol - induced maximal increase in left ventricular systolic pressure was significantly reduced , compared with saline -'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'pretreated rats ( the EC50 of the isoproterenol - induced increase in left ventricular systolic pressure was enhanced approximately 22 - fold ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O B O O O O O O O O O O',\n",
              "  'These results show that 15 - day isoproterenol pretreatment not only abolished but reversed bromocriptine - induced tachycardia to bradycardia , an effect that is mainly related to further cardiac'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'beta - adrenoceptor desensitization rather than to impairment of autonomic regulation of the heart .'],\n",
              " ['O O O O O O O O O O O B O O O O O O O O O B O O O O O O O O',\n",
              "  'They suggest that , in normal conscious rats , the central tachycardia of bromocriptine appears to predominate and to mask the bradycardia of this agonist at peripheral dopamine D2 receptors'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  \"A developmental analysis of clonidine ' s effects on cardiac rate and ultrasound production in infant rats .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Under controlled conditions , infant rats emit ultrasonic vocalizations during extreme cold exposure and after administration of the alpha ( 2 ) adrenoceptor agonist , clonidine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Previous investigations have determined that , in response to clonidine , ultrasound production increases through the 2nd - week postpartum and decreases thereafter .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O',\n",
              "  \"Given that sympathetic neural dominance exhibits a similar developmental pattern , and given that clonidine induces sympathetic withdrawal and bradycardia , we hypothesized that clonidine ' s developmental effects on\"],\n",
              " ['O O O O O O O O O O',\n",
              "  'cardiac rate and ultrasound production would mirror each other .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Therefore , in the present experiment , the effects of clonidine administration ( 0 . 5 mg / kg ) on cardiac rate and ultrasound production were examined in 2'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  '- , 8 - , 15 - , and 20 - day - old rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'Age - related changes in ultrasound production corresponded with changes in cardiovascular variables , including baseline cardiac rate and clonidine - induced bradycardia .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  \"This experiment is discussed with regard to the hypothesis that ultrasound production is the acoustic by - product of a physiological maneuver that compensates for clonidine ' s detrimental effects\"],\n",
              " ['O O O O', 'on cardiovascular function .'],\n",
              " ['O O O O O O O O O O B I O',\n",
              "  'Recurrent use of newer oral contraceptives and the risk of venous thromboembolism .'],\n",
              " ['O O O O O O O O B I O B O O O O O O O O O O O O O O O O O O',\n",
              "  'The epidemiological studies that assessed the risk of venous thromboembolism ( VTE ) associated with newer oral contraceptives ( OC ) did not distinguish between patterns of OC use ,'],\n",
              " ['O O O O O O O O O O',\n",
              "  'namely first - time users , repeaters and switchers .'],\n",
              " ['O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O',\n",
              "  'Data from a Transnational case - control study were used to assess the risk of VTE for the latter patterns of use , while accounting for duration of use .'],\n",
              " ['O O O O O O O O O O B O O O O O O O O O O O O',\n",
              "  'Over the period 1993 - 1996 , 551 cases of VTE were identified in Germany and the UK along with 2066 controls .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Totals of 128 cases and 650 controls were analysed for repeat use and 135 cases and 622 controls for switching patterns .'],\n",
              " ['O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The adjusted rate ratio of VTE for repeat users of third generation OC was 0 . 6 ( 95 % CI : 0 . 3 - 1 . 2 )'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'relative to repeat users of second generation pills , whereas it was 1 . 3 ( 95 % CI : 0 . 7 - 2 . 4 ) for switchers'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'from second to third generation pills relative to switchers from third to second generation pills .'],\n",
              " ['O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O',\n",
              "  'We conclude that second and third generation agents are associated with equivalent risks of VTE when the same agent is used repeatedly after interruption periods or when users are switched'],\n",
              " ['O O O O O O O', 'between the two generations of pills .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'These analyses suggest that the higher risk observed for the newer OC in other studies may be the result of inadequate comparisons of pill users with different patterns of pill'],\n",
              " ['O O', 'use .'],\n",
              " ['O O O O O O O O O O O O B O O O O O O O',\n",
              "  'Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B O O O O O O O B O O',\n",
              "  'We have examined the effect of systemic administration of ketamine and lidocaine on brush - evoked ( dynamic ) pain and punctate - evoked ( static ) hyperalgesia induced by'],\n",
              " ['O O', 'capsaicin .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In a randomized , double - blind , placebo - controlled , crossover study , we studied 12 volunteers in three experiments .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Capsaicin 100 micrograms was injected intradermally on the volar forearm followed by an i . v . infusion of ketamine ( bolus 0 . 1 mg kg - 1 over'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '10 min followed by infusion of 7 micrograms kg - 1 min - 1 ) , lidocaine 5 mg kg - 1 or saline for 50 min .'],\n",
              " ['O O O O O O O O O',\n",
              "  'Infusion started 15 min after injection of capsaicin .'],\n",
              " ['O O O O O O B O B O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The following were measured : spontaneous pain , pain evoked by punctate and brush stimuli ( VAS ) , and areas of brush - evoked and punctate - evoked'],\n",
              " ['B O', 'hyperalgesia .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O B O',\n",
              "  'Ketamine reduced both the area of brush - evoked and punctate - evoked hyperalgesia significantly and it tended to reduce brush - evoked pain .'],\n",
              " ['O O O O O O O O B O O',\n",
              "  'Lidocaine reduced the area of punctate - evoked hyperalgesia significantly .'],\n",
              " ['O O O O O O O O B O O O O O O B O',\n",
              "  'It tended to reduce VAS scores of spontaneous pain but had no effect on evoked pain .'],\n",
              " ['O O O O O O O O O O O B O O O O O O B O O O O O O O O O O O',\n",
              "  'The differential effects of ketamine and lidocaine on static and dynamic hyperalgesia suggest that the two types of hyperalgesia are mediated by separate mechanisms and have a distinct pharmacology .'],\n",
              " ['O O O O O B I O O O O O O O O O O',\n",
              "  'Development of apomorphine - induced aggressive behavior : comparison of adult male and female Wistar rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O',\n",
              "  'The development of apomorphine - induced ( 1 . 0 mg / kg s . c . once daily ) aggressive behavior of adult male and female Wistar rats obtained'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'from the same breeder was studied in two consecutive sets .'],\n",
              " ['O O O O O O O O O O O O B I O O O O O O O B O O O O O O O O',\n",
              "  'In male animals , repeated apomorphine treatment induced a gradual development of aggressive behavior as evidenced by the increased intensity of aggressiveness and shortened latency before the first attack toward'],\n",
              " ['O O O', 'the opponent .'],\n",
              " ['O O O O O O O O O B O O O',\n",
              "  'In female rats , only a weak tendency toward aggressiveness was found .'],\n",
              " ['O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O',\n",
              "  'In conclusion , the present study demonstrates gender differences in the development of the apomorphine - induced aggressive behavior and indicates that the female rats do not fill the validation'],\n",
              " ['O O O O O O O', 'criteria for use in this method .'],\n",
              " ['B I O B I O O O O O O',\n",
              "  'Intracranial aneurysms and cocaine abuse : analysis of prognostic indicators .'],\n",
              " ['O O O O O B I O O B I O O O O',\n",
              "  'OBJECTIVE : The outcome of subarachnoid hemorrhage associated with cocaine abuse is reportedly poor .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'However , no study in the literature has reported the use of a statistical model to analyze the variables that influence outcome .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'METHODS : A review of admissions during a 6 - year period revealed 14 patients with cocaine - related aneurysms .'],\n",
              " ['O O O O O O O O O O O O B I O O O O B I O',\n",
              "  'This group was compared with a control group of 135 patients with ruptured aneurysms and no history of cocaine abuse .'],\n",
              " ['O O O O O O O O O O O O O O O B I O O O O B O O O O B O O O',\n",
              "  'Age at presentation , time of ictus after intoxication , Hunt and Hess grade of subarachnoid hemorrhage , size of the aneurysm , location of the aneurysm , and the'],\n",
              " ['O O O O O O O O O',\n",
              "  'Glasgow Outcome Scale score were assessed and compared .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'RESULTS : The patients in the study group were significantly younger than the patients in the control group ( P < 0 . 002 ) .'],\n",
              " ['O O O O O O O O B O O O O O O O',\n",
              "  'In patients in the study group , all aneurysms were located in the anterior circulation .'],\n",
              " ['O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The majority of these aneurysms were smaller than those of the control group ( 8 + / - 6 . 08 mm versus 11 + / - 5 . 4'],\n",
              " ['O O O O O O O O O', 'mm ; P = 0 . 05 ) .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'The differences in mortality and morbidity between the two groups were not significant .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Hunt and Hess grade ( P < 0 . 005 ) and age ( P < 0 . 007 ) were significant predictors of outcome for the patients with cocaine'],\n",
              " ['O O B O', '- related aneurysms .'],\n",
              " ['O O O O O B I O O O O O O O O O B O',\n",
              "  'CONCLUSION : Cocaine use predisposed aneurysmal rupture at a significantly earlier age and in much smaller aneurysms .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'Contrary to the published literature , this group did reasonably well with aggressive management .'],\n",
              " ['O O O O O O O O O O B I O',\n",
              "  'Effect of intravenous nimodipine on blood pressure and outcome after acute stroke .'],\n",
              " ['O O O O O O O O O B O O O O O O O O O O O B I I I O O O O O',\n",
              "  'BACKGROUND AND PURPOSE : The Intravenous Nimodipine West European Stroke Trial ( INWEST ) found a correlation between nimodipine - induced reduction in blood pressure ( BP ) and an'],\n",
              " ['O O O B I O', 'unfavorable outcome in acute stroke .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'We sought to confirm this correlation with and without adjustment for prognostic variables and to investigate outcome in subgroups with increasing levels of BP reduction .'],\n",
              " ['O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : Patients with a clinical diagnosis of ischemic stroke ( within 24 hours ) were consecutively allocated to receive placebo ( n = 100 ) , 1 mg /'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'h ( low - dose ) nimodipine ( n = 101 ) , or 2 mg / h ( high - dose ) nimodipine ( n = 94 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The correlation between average BP change during the first 2 days and the outcome at day 21 was analyzed .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'RESULTS : Two hundred sixty - five patients were included in this analysis ( n = 92 , 93 , and 80 for placebo , low dose , and high'],\n",
              " ['O O O O O', 'dose , respectively ) .'],\n",
              " ['O O O O O O O B I I I O O O O O O O O O O O O O O O O O O O',\n",
              "  'Nimodipine treatment resulted in a statistically significant reduction in systolic BP ( SBP ) and diastolic BP ( DBP ) from baseline compared with placebo during the first few days'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In multivariate analysis , a significant correlation between DBP reduction and worsening of the neurological score was found for the high - dose group ( beta = 0 . 49'],\n",
              " ['O O O O O O O O', ', P = 0 . 048 ) .'],\n",
              " ['O O O B I O O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'Patients with a DBP reduction of > or = 20 % in the high - dose group had a significantly increased adjusted OR for the compound outcome variable death or'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'dependency ( Barthel Index < 60 ) ( n / N = 25 / 26 , OR 10 . 16 , 95 % CI 1 . 02 to 101 .'],\n",
              " ['O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '74 ) and death alone ( n / N = 9 / 26 , OR 4 . 336 , 95 % CI 1 . 131 16 . 619 ) compared'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'with all placebo patients ( n / N = 62 / 92 and 14 / 92 , respectively ) .'],\n",
              " ['O O O O O O O O O O',\n",
              "  'There was no correlation between SBP change and outcome .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'CONCLUSIONS : DBP , but not SBP , reduction was associated with neurological worsening after the intravenous administration of high - dose nimodipine after acute stroke .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'For low - dose nimodipine , the results were not conclusive .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'These results do not confirm or exclude a neuroprotective property of nimodipine .'],\n",
              " ['O O O B O O O O O',\n",
              "  'Neonatal pyridoxine responsive convulsions due to isoniazid therapy .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O O O O O O B I O',\n",
              "  'A 17 - day - old infant on isoniazid therapy 13 mg / kg daily from birth because of maternal tuberculosis was admitted after 4 days of clonic fits .'],\n",
              " ['O O O O O O O O O O',\n",
              "  'No underlying infective or biochemical cause could be found .'],\n",
              " ['O B O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The fits ceased within 4 hours of administering intramuscular pyridoxine , suggesting an aetiology of pyridoxine deficiency secondary to isoniazid medication .'],\n",
              " ['O O O O O O O O O B O O O O O',\n",
              "  \"Ketamine sedation for the reduction of children ' s fractures in the emergency department .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'BACKGROUND : There recently has been a resurgence in the utilization of ketamine , a unique anesthetic , for emergency - department procedures requiring sedation .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O',\n",
              "  \"The purpose of the present study was to examine the safety and efficacy of ketamine for sedation in the treatment of children ' s fractures in the emergency department .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : One hundred and fourteen children ( average age , 5 . 3 years ; range , twelve months to ten years and ten months ) who underwent closed'],\n",
              " ['O O O O B O B O O O O O O O O O B O O O O O',\n",
              "  'reduction of an isolated fracture or dislocation in the emergency department at a level - I trauma center were prospectively evaluated .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Ketamine hydrochloride was administered intravenously ( at a dose of two milligrams per kilogram of body weight ) in ninety - nine of the patients and intramuscularly ( at a'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'dose of four milligrams per kilogram of body weight ) in the other fifteen .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'A board - certified emergency physician skilled in airway management supervised administration of the anesthetic , and the patients were monitored by a registered nurse .'],\n",
              " ['O B O O O O O O O O O O O O O O O O O O O O O O B O O O O O',\n",
              "  \"Any pain during the reduction was rated by the orthopaedic surgeon treating the patient according to the Children ' s Hospital of Eastern Ontario Pain Scale ( CHEOPS ) .\"],\n",
              " ['O O O O O O O O O O O O O O B O B O O O O O O O O O O O O O',\n",
              "  'RESULTS : The average time from intravenous administration of ketamine to manipulation of the fracture or dislocation was one minute and thirty - six seconds ( range , twenty seconds'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'to five minutes ) , and the average time from intramuscular administration to manipulation was four minutes and forty - two seconds ( range , sixty seconds to fifteen minutes'],\n",
              " ['O O', ') .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O',\n",
              "  \"The average score according to the Children ' s Hospital of Eastern Ontario Pain Scale was 6 . 4 points ( range , 5 to 10 points ) , reflecting\"],\n",
              " ['O O O B O B O O', 'minimal or no pain during fracture reduction .'],\n",
              " ['O B O O O O O O O O O',\n",
              "  'Adequate fracture reduction was obtained in 111 of the children .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Ninety - nine percent ( sixty - eight ) of the sixty - nine parents present during the reduction were pleased with the sedation and would allow it to be'],\n",
              " ['O O O O O O O', 'used again in a similar situation .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'Patency of the airway and independent respiration were maintained in all of the patients .'],\n",
              " ['O O O O O O O O', 'Blood pressure and heart rate remained stable .'],\n",
              " ['O O O O B O O O O O B O O O O O O O B O O B O O O B I O O O',\n",
              "  'Minor side effects included nausea ( thirteen patients ) , emesis ( eight of the thirteen patients with nausea ) , clumsiness ( evident as ataxic movements in ten patients'],\n",
              " ['O O O B I O O O O O', ') , and dysphoric reaction ( one patient ) .'],\n",
              " ['O O O O O O O O O O O O B O O O',\n",
              "  'No long - term sequelae were noted , and no patients had hallucinations or nightmares .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O',\n",
              "  \"CONCLUSIONS : Ketamine reliably , safely , and quickly provided adequate sedation to effectively facilitate the reduction of children ' s fractures in the emergency department at our institution .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Ketamine should only be used in an environment such as the emergency department , where proper one - on - one monitoring is used and board - certified physicians skilled'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'in airway management are directly involved in the care of the patient .'],\n",
              " ['O O O O O B I O',\n",
              "  'Cyclosporine and tacrolimus - associated thrombotic microangiopathy .'],\n",
              " ['O O O B I O B O O O O O O O O O O O O',\n",
              "  'The development of thrombotic microangiopathy ( TMA ) associated with the use of cyclosporine has been well documented .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Treatments have included discontinuation or reduction of cyclosporine dose with or without concurrent plasma exchange , plasma infusion , anticoagulation , and intravenous immunoglobulin G infusion .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'However , for recipients of organ transplantation , removing the inciting agent is not without the attendant risk of precipitating acute rejection and graft loss .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The last decade has seen the emergence of tacrolimus as a potent immunosuppressive agent with mechanisms of action virtually identical to those of cyclosporine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'As a result , switching to tacrolimus has been reported to be a viable therapeutic option in the setting of cyclosporine - induced TMA .'],\n",
              " ['O O O O O O O O O O O O O O B O O O O O',\n",
              "  'With the more widespread application of tacrolimus in organ transplantation , tacrolimus - associated TMA has also been recognized .'],\n",
              " ['O O O O O O O O O O B O O O O O O O O O O O',\n",
              "  'However , literature regarding the incidence of the recurrence of TMA in patients exposed sequentially to cyclosporine and tacrolimus is limited .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O',\n",
              "  'We report a case of a living donor renal transplant recipient who developed cyclosporine - induced TMA that responded to the withdrawal of cyclosporine in conjunction with plasmapheresis and fresh'],\n",
              " ['O O O O O', 'frozen plasma replacement therapy .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O',\n",
              "  'Introduction of tacrolimus as an alternative immunosuppressive agent resulted in the recurrence of TMA and the subsequent loss of the renal allograft .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'Patients who are switched from cyclosporine to tacrolimus or vice versa should be closely monitored for the signs and symptoms of recurrent TMA .'],\n",
              " ['O O O O O O B O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Analgesic effect of intravenous ketamine in cancer patients on morphine therapy : a randomized , controlled , double - blind , crossover , double - dose study .'],\n",
              " ['B O O O O O O O O',\n",
              "  'Pain not responsive to morphine is often problematic .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Animal and clinical studies have suggested that N - methyl - D - aspartate ( NMDA ) antagonists , such as ketamine , may be effective in improving opioid analgesia'],\n",
              " ['O O B O O O O B I O',\n",
              "  'in difficult pain syndromes , such as neuropathic pain .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O',\n",
              "  'A slow bolus of subhypnotic doses of ketamine ( 0 . 25 mg / kg or 0 . 50 mg / kg ) was given to 10 cancer patients whose'],\n",
              " ['B O O O O O O O O O O O O O O O O O O O',\n",
              "  'pain was unrelieved by morphine in a randomized , double - blind , crossover , double - dose study .'],\n",
              " ['B O O O O O O O O O B O B O O O B O O B I O O O O O O O O O',\n",
              "  'Pain intensity on a 0 to 10 numerical scale ; nausea and vomiting , drowsiness , confusion , and dry mouth , using a scale from 0 to 3 ('],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'not at all , slight , a lot , awful ) ; Mini - Mental State Examination ( MMSE ) ( 0 - 30 ) ; and arterial pressure were'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'recorded before administration of drugs ( T0 ) and after 30 minutes ( T30 ) , 60 minutes ( T60 ) , 120 minutes ( T120 ) , and 180'],\n",
              " ['O O O O O', 'minutes ( T180 ) .'],\n",
              " ['O O O O O O O O O O B O O O O O O O O O O',\n",
              "  'Ketamine , but not saline solution , significantly reduced the pain intensity in almost all the patients at both doses .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'This effect was more relevant in patients treated with higher doses .'],\n",
              " ['B O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Hallucinations occurred in 4 patients , and an unpleasant sensation ( \" empty head \" ) was also reported by 2 patients .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'These episodes reversed after the administration of diazepam 1 mg intravenously .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Significant increases in drowsiness were reported in patients treated with ketamine in both groups and were more marked with ketamine 0 . 50 mg / kg .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'A significant difference in MMSE was observed at T30 in patients who received 0 . 50 mg / kg of ketamine .'],\n",
              " ['O O O O O O O B O O O O B I O',\n",
              "  'Ketamine can improve morphine analgesia in difficult pain syndromes , such as neuropathic pain .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'However , the occurrence of central adverse effects should be taken into account , especially when using higher doses .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'This observation should be tested in studies of prolonged ketamine administration .'],\n",
              " ['O O O O O O O O O O O O O O O B I I I O',\n",
              "  'Paclitaxel , cisplatin , and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma .'],\n",
              " ['O O O O O O O O O O O O O O O B I I I O B O O',\n",
              "  'BACKGROUND : Cisplatin - based chemotherapy combinations improve quality of life and survival in advanced nonsmall cell lung carcinoma ( NSCLC ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'The emergence of new active drugs might translate into more effective regimens for the treatment of this disease .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O',\n",
              "  'METHODS : The objective of this study was to determine the feasibility , response rate , and toxicity of a paclitaxel , cisplatin , and gemcitabine combination to treat metastatic'],\n",
              " ['B O', 'NSCLC .'],\n",
              " ['O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O',\n",
              "  'Thirty - five consecutive chemotherapy - naive patients with Stage IV NSCLC and an Eastern Cooperative Oncology Group performance status of 0 - 2 were treated with a combination of'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'paclitaxel ( 135 mg / m ( 2 ) given intravenously in 3 hours ) on Day 1 , cisplatin ( 120 mg / m ( 2 ) given intravenously'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'in 6 hours ) on Day 1 , and gemcitabine ( 800 mg / m ( 2 ) given intravenously in 30 minutes ) on Days 1 and 8 ,'],\n",
              " ['O O O O', 'every 4 weeks .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O',\n",
              "  'Although responding patients were scheduled to receive consolidation radiotherapy and 24 patients received preplanned second - line chemotherapy after disease progression , the response and toxicity rates reported refer only'],\n",
              " ['O O O O O O', 'to the chemotherapy regimen given .'],\n",
              " ['O O O O O O O O B O O O O O O O',\n",
              "  'RESULTS : All the patients were examined for toxicity ; 34 were examinable for response .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'An objective response was observed in 73 . 5 % of the patients ( 95 % confidence interval [ CI ] , 55 . 6 - 87 . 1 %'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  ') , including 4 complete responses ( 11 . 7 % ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'According to intention - to - treat , the overall response rate was 71 . 4 % ( 95 % CI , 53 . 7 - 85 . 4 %'],\n",
              " ['O O', ') .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'After 154 courses of therapy , the median dose intensity was 131 mg / m ( 2 ) for paclitaxel ( 97 . 3 % ) , 117 mg /'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'm ( 2 ) for cisplatin ( 97 . 3 % ) , and 1378 mg / m ( 2 ) for gemcitabine ( 86 . 2 % ) .'],\n",
              " ['O O O O O O O B O B O O O O O O O O O O O O O O O O',\n",
              "  'World Health Organization Grade 3 - 4 neutropenia and thrombocytopenia occurred in 39 . 9 % and 11 . 4 % of patients , respectively .'],\n",
              " ['O O O O O O B O', 'There was one treatment - related death .'],\n",
              " ['O B O O O', 'Nonhematologic toxicities were mild .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'After a median follow - up of 22 months , the median progression free survival rate was 7 months , and the median survival time was 16 months .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'CONCLUSIONS : The combination of paclitaxel , cisplatin , and gemcitabine is well tolerated and shows high activity in metastatic NSCLC .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'This treatment merits further comparison with other cisplatin - based regimens .'],\n",
              " ['O O O B I O', 'Serotonergic antidepressants and urinary incontinence .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'Many new serotonergic antidepressants have been introduced over the past decade .'],\n",
              " ['O B I O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Although urinary incontinence is listed as one side effect of these drugs in their package inserts there is only one report in the literature .'],\n",
              " ['O O O O O O O B O O O O',\n",
              "  'This concerns 2 male patients who experienced incontinence while taking venlafaxine .'],\n",
              " ['O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O',\n",
              "  'In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline , as well as a third who'],\n",
              " ['O O O O O O O', 'developed this side effect on venlafaxine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'In 2 of the 3 cases the patients were also taking lithium carbonate and beta - blockers , both of which could have contributed to the incontinence .'],\n",
              " ['O O O O B O O O O O O O O O O O O O O O O',\n",
              "  'Animal studies suggest that incontinence secondary to serotonergic antidepressants could be mediated by the 5HT4 receptors found on the bladder .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Further research is needed to delineate the frequency of this troubling side effect and how best to treat it .'],\n",
              " ['O O O O B O O O O O O O O O',\n",
              "  'Acute cocaine - induced seizures : differential sensitivity of six inbred mouse strains .'],\n",
              " ['O O O O O O O O O O O O O O O B O O O O O O O O',\n",
              "  'Mature male and female mice from six inbred stains were tested for susceptibility to behavioral seizures induced by a single injection of cocaine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Cocaine was injected ip over a range of doses ( 50 - 100 mg / kg ) and behavior was monitored for 20 minutes .'],\n",
              " ['B O O O O O O O O O O O O O O B O O O O O B O',\n",
              "  'Seizure end points included latency to forelimb or hindlimb clonus , latency to clonic running seizure and latency to jumping bouncing seizure .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'A range of strain specific sensitivities was documented with A / J and SJL mice being most sensitive and C57BL / 6J most resistant .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'DBA / 2J , BALB / cByJ and NZW / LacJ strains exhibited intermediate sensitivity .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'EEG recordings were made in SJL , A / J and C57BL / 6J mice revealing a close correspondence between electrical activity and behavior .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Additionally , levels of cocaine determined in hippocampus and cortex were not different between sensitive and resistant strains .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O',\n",
              "  'Additional studies of these murine strains may be useful for investigating genetic influences on cocaine - induced seizures .'],\n",
              " ['B O O O O O O O O O O O O O O O O O B O',\n",
              "  'Hypotension following the initiation of tizanidine in a patient treated with an angiotensin converting enzyme inhibitor for chronic hypertension .'],\n",
              " ['O O O O O O O O O O O O O O O O O O B O O B I I I I I O',\n",
              "  'Centrally acting alpha - 2 adrenergic agonists are one of several pharmacologic agents used in the treatment of spasticity related to disorders of the central nervous system .'],\n",
              " ['O O O O O O B O O O O O O O O O',\n",
              "  'In addition to their effects on spasticity , certain adverse cardiorespiratory effects have been reported .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O',\n",
              "  'Adults chronically treated with angiotensin converting enzyme inhibitors may have a limited ability to respond to hypotension when the sympathetic response is simultaneously blocked .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O B O O B O O O',\n",
              "  'The authors present a 10 - year - old boy chronically treated with lisinopril , an angiotensin converting enzyme inhibitor , to control hypertension who developed hypotension following the addition'],\n",
              " ['O O O O O O O O O O O O O B O',\n",
              "  'of tizanidine , an alpha - 2 agonist , for the treatment of spasticity .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O B O O O O',\n",
              "  'The possible interaction of tizanidine and other antihypertensive agents should be kept in mind when prescribing therapy to treat either hypertension or spasticity in such patients .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O',\n",
              "  'Two mouse lines selected for differential sensitivities to beta - carboline - induced seizures are also differentially sensitive to various pharmacological effects of other GABA ( A ) receptor ligands'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O',\n",
              "  'Two mouse lines were selectively bred according to their sensitivity ( BS line ) or resistance ( BR line ) to seizures induced by a single i . p .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'injection of methyl beta - carboline - 3 - carboxylate ( beta - CCM ) , an inverse agonist of the GABA ( A ) receptor benzodiazepine site .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  \"Our aim was to characterize both lines ' sensitivities to various physiological effects of other ligands of the GABA ( A ) receptor .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'We measured diazepam - induced anxiolysis with the elevated plus - maze test , diazepam - induced sedation by recording the vigilance states , and picrotoxin - and pentylenetetrazol -'],\n",
              " ['O B O O O O O O O', 'induced seizures after i . p . injections .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Results presented here show that the differential sensitivities of BS and BR lines to beta - CCM can be extended to diazepam , picrotoxin , and pentylenetetrazol , suggesting a'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'genetic selection of a general sensitivity and resistance to several ligands of the GABA ( A ) receptor .'],\n",
              " ['O O O O O O O O O O O B O O O B O',\n",
              "  'Propylthiouracil - induced perinuclear - staining antineutrophil cytoplasmic autoantibody - positive vasculitis in conjunction with pericarditis .'],\n",
              " ['O O O O O O O O O O B O O B O',\n",
              "  'OBJECTIVE : To describe a case of propylthiouracil - induced vasculitis manifesting with pericarditis .'],\n",
              " ['O O O O O O O O O O O O B O O O O O O O O B O B O O B O O',\n",
              "  'METHODS : We present the first case report of a woman with hyperthyroidism treated with propylthiouracil in whom a syndrome of pericarditis , fever , and glomerulonephritis developed .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'Serologic testing and immunologic studies were done , and a pericardial biopsy was performed .'],\n",
              " ['O O O O O O O O O O B I I O O B I O O O B O O O O O O O',\n",
              "  \"RESULTS : A 25 - year - old woman with Graves ' disease had a febrile illness and evidence of pericarditis , which was confirmed by biopsy .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Serologic evaluation revealed the presence of perinuclear - staining antineutrophil cytoplasmic autoantibodies ( pANCA ) against myeloperoxidase ( MPO ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Propylthiouracil therapy was withdrawn , and she was treated with a 1 - month course of prednisone , which alleviated her symptoms .'],\n",
              " ['O O O O O O O O B O O O O O O O B O O O O O O O',\n",
              "  'A literature review revealed no prior reports of pericarditis in anti - MPO pANCA - positive vasculitis associated with propylthio - uracil therapy .'],\n",
              " ['O O B O O O O O O O O O B O O O O O O O',\n",
              "  'CONCLUSION : Pericarditis may be the initial manifestation of drug - induced vasculitis attributable to propylthio - uracil therapy .'],\n",
              " ['O O B O O O O O O O O O O O',\n",
              "  'Repeated transient anuria following losartan administration in a patient with a solitary kidney .'],\n",
              " ['O O O O O O O O O O O B O O O O O O B I I O O O O O O B O O',\n",
              "  'We report the case of a 70 - year - old hypertensive man with a solitary kidney and chronic renal insufficiency who developed two episodes of transient anuria after losartan'],\n",
              " ['O O', 'administration .'],\n",
              " ['O O O O O B I O B I O O O O O O O O',\n",
              "  'He was hospitalized for a myocardial infarction with pulmonary edema , treated with high - dose diuretics .'],\n",
              " ['O O O B I O O O O',\n",
              "  'Due to severe systolic dysfunction losartan was prescribed .'],\n",
              " ['O O O O O O O O O O O O O O B O O O O O O O O O O O O O O',\n",
              "  'Surprisingly , the first dose of 50 mg of losartan resulted in a sudden anuria , which lasted eight hours despite high - dose furosemide and amine infusion .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'One week later , by mistake , losartan was prescribed again and after the second dose of 50 mg , the patient developed a second episode of transient anuria lasting'],\n",
              " ['O O O', '10 hours .'],\n",
              " ['O O O O O O O O O O O O B O O O',\n",
              "  'During these two episodes , his blood pressure diminished but no severe hypotension was noted .'],\n",
              " ['O O O O O O O O O O B I I O',\n",
              "  'Ultimately , an arteriography showed a 70 - 80 % renal artery stenosis .'],\n",
              " ['O O O O B I I O O B I O O O O O O O O O O O O O O O O O O O',\n",
              "  'In this patient , renal artery stenosis combined with heart failure and diuretic therapy certainly resulted in a strong activation of the renin - angiotensin system ( RAS ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Under such conditions , angiotensin II receptor blockade by losartan probably induced a critical fall in glomerular filtration pressure .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O',\n",
              "  'This case report highlights the fact that the angiotensin II receptor antagonist losartan can cause serious unexpected complications in patients with renovascular disease and should be used with extreme caution'],\n",
              " ['O O O O', 'in this setting .'],\n",
              " ['O O O O B O O B O O O O O O O O O O',\n",
              "  'Calcineurin - inhibitor induced pain syndrome ( CIPS ) : a severe disabling complication after organ transplantation .'],\n",
              " ['O B O O O O O O O O O O O O O O',\n",
              "  'Bone pain after transplantation is a frequent complication that can be caused by several diseases .'],\n",
              " ['O O O O O O O O O B O',\n",
              "  'Treatment strategies depend on the correct diagnosis of the pain .'],\n",
              " ['O O O O B O O O O O O O O O O O O O',\n",
              "  'Nine patients with severe pain in their feet , which was registered after transplantation , were investigated .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'Bone scans showed an increased tracer uptake of the foot bones .'],\n",
              " ['O O O O B I I O O O O O',\n",
              "  'Magnetic resonance imaging demonstrated bone marrow oedema in the painful bones .'],\n",
              " ['B O O O O O O O O B O O B I I O B O B I I I O B O B O B I O',\n",
              "  \"Pain was not explained by other diseases causing foot pain , like reflex sympathetic dystrophy , polyneuropathy , Morton ' s neuralgia , gout , osteoporosis , avascular necrosis ,\"],\n",
              " ['B I O O B I O B I O O B O',\n",
              "  'intermittent claudication , orthopaedic foot deformities , stress fractures , and hyperparathyroidism .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'The reduction of cyclosporine - or tacrolimus trough levels and the administration of calcium channel blockers led to relief of pain .'],\n",
              " ['O O O O O B O O B O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The Calcineurin - inhibitor Induced Pain Syndrome ( CIPS ) is a rare but severe side effect of cyclosporine or tacrolimus and is accurately diagnosed by its typical presentation ,'],\n",
              " ['O O O O O O O', 'magnetic resonance imaging and bone scans .'],\n",
              " ['O O O O O O O O O O O O O O O O O O B O',\n",
              "  'Incorrect diagnosis of the syndrome will lead to a significant reduction of life quality in patients suffering from CIPS .'],\n",
              " ['O O O O O O O O O O B O',\n",
              "  'Brain natriuretic peptide is a predictor of anthracycline - induced cardiotoxicity .'],\n",
              " ['O O O O O O O O O O O O O B O',\n",
              "  'Anthracyclines are effective antineoplastic drugs , but they frequently cause dose - related cardiotoxicity .'],\n",
              " ['O B O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'The cardiotoxicity of conventional anthracycline therapy highlights a need to search for methods that are highly sensitive and capable of predicting cardiac dysfunction .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O',\n",
              "  'We measured the plasma level of brain natriuretic peptide ( BNP ) to determine whether BNP might serve as a simple diagnostic indicator of anthracycline - induced cardiotoxicity in patients'],\n",
              " ['O B I O O O O O O O O O O O',\n",
              "  'with acute leukemia treated with a daunorubicin ( DNR ) - containing regimen .'],\n",
              " ['O O O B I O O O O O O O O O',\n",
              "  'Thirteen patients with acute leukemia were treated with a DNR - containing regimen .'],\n",
              " ['O O O O O O O O O O',\n",
              "  'Cardiac functions were evaluated with radionuclide angiography before chemotherapies .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The plasma levels of atrial natriuretic peptide ( ANP ) and BNP were measured at the time of radionuclide angiography .'],\n",
              " ['O O O B I I O O O O O O',\n",
              "  'Three patients developed congestive heart failure after the completion of chemotherapy .'],\n",
              " ['O O O O O O O B I O O O O O O',\n",
              "  'Five patients were diagnosed as having subclinical heart failure after the completion of chemotherapy .'],\n",
              " ['O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'The plasma levels of BNP in all the patients with clinical and subclinical heart failure increased above the normal limit ( 40 pg / ml ) before the detection of'],\n",
              " ['O O O B I O O O O',\n",
              "  'clinical or subclinical heart failure by radionuclide angiography .'],\n",
              " ['O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'On the other hand , BNP did not increase in the patients without heart failure given DNR , even at more than 700 mg / m ( 2 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O B I O',\n",
              "  'The plasma level of ANP did not always increase in all the patients with clinical and subclinical heart failure .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'These preliminary results suggest that BNP may be useful as an early and sensitive indicator of anthracycline - induced cardiotoxicity .'],\n",
              " ['B O O O O O O O',\n",
              "  'Nephrotoxicity of combined cephalothin - gentamicin regimen .'],\n",
              " ['O O O B I I O O O O O B I I O O O O O O O O O O O O O O O',\n",
              "  'Two patients developed acute tubular necrosis , characterized clinically by acute oliguric renal failure , while they were receiving a combination of cephalothin sodium and gentamicin sulfate therapy .'],\n",
              " ['O O O O O O O O O O O O O O O O B O',\n",
              "  'Patients who are given this drug regimen should be observed very carefully for early signs of nephrotoxicity .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'High doses of this antibiotic combination should be avoided especially in elderly patients .'],\n",
              " ['O O B I O O O O O O O',\n",
              "  'Patients with renal insufficiency should not be given this regimen .'],\n",
              " ['O O O O O O O O O B O O O O O O B O O O O B I O O O O B O O',\n",
              "  'In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen - induced nephrotoxicity , amiodarone - induced lung toxicity and doxorubicin - induced cardiotoxicity by a'],\n",
              " ['O O O O O O O', 'novel IH636 grape seed proanthocyanidin extract .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Grape seed extract , primarily a mixture of proanthocyanidins , has been shown to modulate a wide - range of biological , pharmacological and toxicological effects which are mainly cytoprotective'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O',\n",
              "  'This study assessed the ability of IH636 grape seed proanthocyanidin extract ( GSPE ) to prevent acetaminophen ( AAP ) - induced nephrotoxicity , amiodarone ( AMI ) - induced'],\n",
              " ['B I O O O O O O O O B O O O',\n",
              "  'lung toxicity , and doxorubicin ( DOX ) - induced cardiotoxicity in mice .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Experimental design consisted of four groups : control ( vehicle alone ) , GSPE alone , drug alone and GSPE + drug .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'For the cytoprotection study , animals were orally gavaged 100 mg / Kg GSPE for 7 - 10 days followed by i . p . injections of organ specific three'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'drugs ( AAP : 500 mg / Kg for 24 h ; AMI : 50 mg / Kg / day for four days ; DOX : 20 mg / Kg'],\n",
              " ['O O O O O', 'for 48 h ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Parameters of study included analysis of serum chemistry ( ALT , BUN and CPK ) , and orderly fragmentation of genomic DNA ( both endonuclease - dependent and independent )'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'in addition to microscopic evaluation of damage and / or protection in corresponding PAS stained tissues .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Results indicate that GSPE preexposure prior to AAP , AMI and DOX , provided near complete protection in terms of serum chemistry changes ( ALT , BUN and CPK )'],\n",
              " ['O O O O O O O', ', and significantly reduced DNA fragmentation .'],\n",
              " ['O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'Histopathological examination of kidney , heart and lung sections revealed moderate to massive tissue damage with a variety of morphological aberrations by all the three drugs in the absence of'],\n",
              " ['O O O O O O O', 'GSPE preexposure than in its presence .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'GSPE + drug exposed tissues exhibited minor residual damage or near total recovery .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'Additionally , histopathological alterations mirrored both serum chemistry changes and the pattern of DNA fragmentation .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O',\n",
              "  'Interestingly , all the drugs , such as , AAP , AMI and DOX induced apoptotic death in addition to necrosis in the respective organs which was very effectively blocked'],\n",
              " ['O O O', 'by GSPE .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Since AAP , AMI and DOX undergo biotransformation and are known to produce damaging radicals in vivo , the protection by GSPE may be linked to both inhibition of metabolism'],\n",
              " ['O O O O O O O O', 'and / or detoxification of cytotoxic radicals .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  \"In addition , its ' presumed contribution to DNA repair may be another important attribute , which played a role in the chemoprevention process .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Additionally , this may have been the first report on AMI - induced apoptotic death in the lung tissue .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  \"Taken together , these events undoubtedly establish GSPE ' s abundant bioavailability , and the power to defend multiple target organs from toxic assaults induced by structurally diverse and functionally\"],\n",
              " ['O O O O O', 'different entities in vivo .'],\n",
              " ['O O O B O B O O O O O O O',\n",
              "  'Antidepressant - induced mania in bipolar patients : identification of risk factors .'],\n",
              " ['O O O O O O O O O B O O O O O O O O O O O O O O O B I O',\n",
              "  'BACKGROUND : Concerns about possible risks of switching to mania associated with antidepressants continue to interfere with the establishment of an optimal treatment paradigm for bipolar depression .'],\n",
              " ['O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'METHOD : The response of 44 patients meeting DSM - IV criteria for bipolar disorder to naturalistic treatment was assessed for at least 6 weeks using the Montgomery - Asberg'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'Depression Rating Scale and the Bech - Rafaelson Mania Rating Scale .'],\n",
              " ['O O O O B O B O O O O O O O O O O O O O O O O O O',\n",
              "  'Patients who experienced a manic or hypomanic switch were compared with those who did not on several variables including age , sex , diagnosis ('],\n",
              " ['B I I I I O O B I O O O O O B O O O O O O O O O O O O O O O',\n",
              "  'DSM - IV bipolar I vs . bipolar II ) , number of previous manic episodes , type of antidepressant therapy used ( electroconvulsive therapy vs . antidepressant drugs and'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  ', more particularly , selective serotonin reuptake inhibitors [ SSRIs ] ) , use and type of mood stabilizers ( lithium vs . anticonvulsants ) , and temperament of the'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'patient , assessed during a normothymic period using the hyperthymia component of the Semi - structured Affective Temperament Interview .'],\n",
              " ['O O O O B O B O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'RESULTS : Switches to hypomania or mania occurred in 27 % of all patients ( N = 12 ) ( and in 24 % of the subgroup of patients treated'],\n",
              " ['O O O O O O O O O O O O O O O O O B O O O O O O O O O O O',\n",
              "  'with SSRIs [ 8 / 33 ] ) ; 16 % ( N = 7 ) experienced manic episodes , and 11 % ( N = 5 ) experienced'],\n",
              " ['B O O', 'hypomanic episodes .'],\n",
              " ['O O O O O O B I O O B I O O O O O O O O O O O O O',\n",
              "  'Sex , age , diagnosis ( bipolar I vs . bipolar II ) , and additional treatment did not affect the risk of switching .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The incidence of mood switches seemed not to differ between patients receiving an anticonvulsant and those receiving no mood stabilizer .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In contrast , mood switches were less frequent in patients receiving lithium ( 15 % , 4 / 26 ) than in patients not treated with lithium ( 44 %'],\n",
              " ['O O O O O O O O O O O', ', 8 / 18 ; p = . 04 ) .'],\n",
              " ['O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The number of previous manic episodes did not affect the probability of switching , whereas a high score on the hyperthymia component of the Semistructured Affective Temperament Interview was associated'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'with a greater risk of switching ( p = . 008 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'CONCLUSION : The frequency of mood switching associated with acute antidepressant therapy may be reduced by lithium treatment .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Particular attention should be paid to patients with a hyperthymic temperament , who have a greater risk of mood switches .'],\n",
              " ['O O O O O O O O O B I O O O O O O O O O O',\n",
              "  'Peritubular capillary basement membrane reduplication in allografts and native kidney disease : a clinicopathologic study of 278 consecutive renal specimens .'],\n",
              " ['O O O O O O O O B I O B O O O O O O O O O O O O',\n",
              "  'BACKGROUND : An association has been found between transplant glomerulopathy ( TG ) and reduplication of peritubular capillary basement membranes ( PTCR ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Although such an association is of practical and theoretical importance , only one prospective study has tried to confirm it .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : We examined 278 consecutive renal specimens ( from 135 transplants and 143 native kidneys ) for ultrastructural evidence of PTCR .'],\n",
              " ['O O O O O O B O O O O O O O O O O B O B I I O O O O O O O O',\n",
              "  'In addition to renal allografts with TG , we also examined grafts with acute rejection , recurrent glomerulonephritis , chronic allograft nephropathy and stable grafts ( \" protocol biopsies \"'],\n",
              " ['O O', ') .'],\n",
              " ['O O O O O O O O B O O O O O B I O B I O O B I O O B I I O',\n",
              "  'Native kidney specimens included a wide range of glomerulopathies as well as cases of thrombotic microangiopathy , malignant hypertension , acute interstitial nephritis , and acute tubular necrosis .'],\n",
              " ['O O O O O O O O O O O B O O O O O O O B O O O O O O O O O O',\n",
              "  'RESULTS : We found PTCR in 14 of 15 cases of TG , in 7 transplant biopsy specimens without TG , and in 13 of 143 native kidney biopsy specimens'],\n",
              " ['O', '.'],\n",
              " ['O O O O O B I O B I O B I O B I I I O O B O O O O O B I I O',\n",
              "  'These 13 included cases of malignant hypertension , thrombotic microangiopathy , lupus nephritis , Henoch - Schonlein nephritis , crescentic glomerulonephritis , and cocaine - related acute renal failure .'],\n",
              " ['O O O O O B O O O B I O O B O O O O O O O O O O O O O',\n",
              "  'Mild PTCR in allografts without TG did not predict renal failure or significant proteinuria after follow - up periods of between 3 months and 1 year .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O',\n",
              "  'CONCLUSIONS : We conclude that in transplants , there is a strong association between well - developed PTCR and TG , while the significance of mild PTCR and its predictive'],\n",
              " ['O O O O O B O O O', 'value in the absence of TG is unclear .'],\n",
              " ['O O O O O O B I O O O O O O O O O O O B O',\n",
              "  'PTCR also occurs in certain native kidney diseases , though the association is not as strong as that for TG .'],\n",
              " ['O O O O B I O O B I O O O O O O O O O O O O O O O',\n",
              "  'We suggest that repeated endothelial injury , including immunologic injury , may be the cause of this lesion both in allografts and native kidneys .'],\n",
              " ['O O O B I O O O O O O O O',\n",
              "  'Caffeine - induced cardiac arrhythmia : an unrecognised danger of healthfood products .'],\n",
              " ['O O O O O O O O O O O O O B I I O O O B I O O O O O O O O O',\n",
              "  'We describe a 25 - year - old woman with pre - existing mitral valve prolapse who developed intractable ventricular fibrillation after consuming a \" natural energy \" guarana health'],\n",
              " ['O O O O O O O O', 'drink containing a high concentration of caffeine .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'This case highlights the need for adequate labelling and regulation of such products .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti - cocaine effects in mice .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  \"Cocaine ' s ability to interact with sigma receptors suggests that these proteins mediate some of its behavioral effects .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Therefore , three novel sigma receptor ligands with antagonist activity were evaluated in Swiss Webster mice : BD1018 ( 3S - 1 - [ 2 - ( 3 , 4'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '- dichlorophenyl ) ethyl ] - 1 , 4 - diazabicyclo [ 4 . 3 . 0 ] nonane ) , BD1063 ( 1 - [ 2 - ( 3'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  ', 4 - dichlorophenyl ) ethyl ] - 4 - methylpiperazine ) , and LR132 ( 1R , 2S - ( + ) - cis - N - [ 2'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '- ( 3 , 4 - dichlorophenyl ) ethyl ] - 2 - ( 1 - pyrrolidinyl ) cyclohexylamine ) .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'Competition binding assays demonstrated that all three compounds have high affinities for sigma1 receptors .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The three compounds vary in their affinities for sigma2 receptors and exhibit negligible affinities for dopamine , opioid , GABA ( A ) and NMDA receptors .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B O O O',\n",
              "  'In behavioral studies , pre - treatment of mice with BD1018 , BD1063 , or LR132 significantly attenuated cocaine - induced convulsions and lethality .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Moreover , post - treatment with LR132 prevented cocaine - induced lethality in a significant proportion of animals .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In contrast to the protection provided by the putative antagonists , the well - characterized sigma receptor agonist di - o - tolylguanidine ( DTG ) and the novel sigma'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'receptor agonist BD1031 ( 3R - 1 - [ 2 - ( 3 , 4 - dichlorophenyl ) ethyl ] - 1 , 4 - diazabicyclo [ 4 . 3'],\n",
              " ['O O O O O O O O O B O O O',\n",
              "  '. 0 ] nonane ) each worsened the behavioral toxicity of cocaine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'At doses where alone , they produced no significant effects on locomotion , BD1018 , BD1063 and LR132 significantly attenuated the locomotor stimulatory effects of cocaine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'To further validate the hypothesis that the anti - cocaine effects of the novel ligands involved antagonism of sigma receptors , an antisense oligodeoxynucleotide against sigma1 receptors was also shown'],\n",
              " ['O O O O B O O O O O O O',\n",
              "  'to significantly attenuate the convulsive and locomotor stimulatory effects of cocaine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Together , the data suggests that functional antagonism of sigma receptors is capable of attenuating a number of cocaine - induced behaviors .'],\n",
              " ['O O O O B I O O O O O O',\n",
              "  'Ranitidine - induced acute interstitial nephritis in a cadaveric renal allograft .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'Ranitidine frequently is used for preventing peptic ulceration after renal transplantation .'],\n",
              " ['O O O O O O O O B I O O O O',\n",
              "  'This drug occasionally has been associated with acute interstitial nephritis in native kidneys .'],\n",
              " ['O O O O O O O O O',\n",
              "  'There are no similar reports with renal transplantation .'],\n",
              " ['O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O',\n",
              "  'We report a case of ranitidine - induced acute interstitial nephritis in a recipient of a cadaveric renal allograft presenting with acute allograft dysfunction within 48 hours of exposure to'],\n",
              " ['O O O', 'the drug .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'The biopsy specimen showed pathognomonic features , including eosinophilic infiltration of the interstitial compartment .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'Allograft function improved rapidly and returned to baseline after stopping the drug .'],\n",
              " ['B I O O O O', 'Liver disease caused by propylthiouracil .'],\n",
              " ['O O O O O O O O O O O O O O O O O O B I I I I I O O O O O O',\n",
              "  'This report presents the clinical , laboratory , and light and electron microscopic observations on a patient with chronic active ( aggressive ) hepatitis caused by the administration of propylthiouracil'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'This is an addition to the list of drugs that must be considered in the evaluation of chronic liver disease .'],\n",
              " ['B I I I I O O O O O O',\n",
              "  'Withdrawal - emergent rabbit syndrome during dose reduction of risperidone .'],\n",
              " ['B I O B O O O O O O O O O O O O O',\n",
              "  'Rabbit syndrome ( RS ) is a rare extrapyramidal side effect caused by prolonged neuroleptic medication .'],\n",
              " ['O O O O O O B I I I O O O O O O O O O O O O',\n",
              "  'Here we present a case of withdrawal - emergent RS , which is the first of its kind to be reported .'],\n",
              " ['O O O B O O O O O O',\n",
              "  'The patient developed RS during dose reduction of risperidone .'],\n",
              " ['O O O O O O O O O O',\n",
              "  'The symptom was treated successfully with trihexyphenidyl anticholinergic therapy .'],\n",
              " ['O O O O B I I I O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The underlying mechanism of withdrawal - emergent RS in the present case may have been related to the pharmacological profile of risperidone , a serotonin - dopamine antagonist , suggesting'],\n",
              " ['O O O O O O O O O O O B O',\n",
              "  'the pathophysiologic influence of the serotonin system in the development of RS .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Pharmacokinetic / pharmacodynamic assessment of the effects of E4031 , cisapride , terfenadine and terodiline on monophasic action potential duration in dog .'],\n",
              " ['O O', '1 .'],\n",
              " ['B I I O B O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'Torsades de pointes ( TDP ) is a potentially fatal ventricular tachycardia associated with increases in QT interval and monophasic action potential duration ( MAPD ) .'],\n",
              " ['B O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'TDP is a side - effect that has led to withdrawal of several drugs from the market ( e . g . terfenadine and terodiline ) .'],\n",
              " ['O O', '2 .'],\n",
              " ['O O O O O O B O O O O O O O O O O O',\n",
              "  'The potential of compounds to cause TDP was evaluated by monitoring their effects on MAPD in dog .'],\n",
              " ['O O O O O O O O O B O O O O O O O O O O O',\n",
              "  'Four compounds known to increase QT interval and cause TDP were investigated : terfenadine , terodiline , cisapride and E4031 .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'On the basis that only free drug in the systemic circulation will elicit a pharmacological response target , free concentrations in plasma were selected to mimic the free drug exposures'],\n",
              " ['O O O', 'in man .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Infusion regimens were designed that rapidly achieved and maintained target - free concentrations of these drugs in plasma and data on the relationship between free concentration and changes in MAPD'],\n",
              " ['O O O O O O', 'were obtained for these compounds .'],\n",
              " ['O O', '3 .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'These data indicate that the free ED50 in plasma for terfenadine ( 1 . 9 nM ) , terodiline ( 76 nM ) , cisapride ( 11 nM ) and'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'E4031 ( 1 . 9 nM ) closely correlate with the free concentration in man causing QT effects .'],\n",
              " ['O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'For compounds that have shown TDP in the clinic ( terfenadine , terodiline , cisapride ) there is little differentiation between the dog ED50 and the efficacious free plasma concentrations'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'in man ( < 10 - fold ) reflecting their limited safety margins .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O',\n",
              "  'These data underline the need to maximize the therapeutic ratio with respect to TDP in potential development candidates and the importance of using free drug concentrations in pharmacokinetic / pharmacodynamic'],\n",
              " ['O O', 'studies .'],\n",
              " ['O B I I O O O O O O O O O O O O O O',\n",
              "  'Bladder retention of urine as a result of continuous intravenous infusion of fentanyl : 2 case reports .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O',\n",
              "  'Sedation has been commonly used in the neonate to decrease the stress and pain from the noxious stimuli and invasive procedures in the neonatal intensive care unit , as well'],\n",
              " ['O O O O O O O O O O',\n",
              "  'as to facilitate synchrony between ventilator and spontaneous breaths .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Fentanyl , an opioid analgesic , is frequently used in the neonatal intensive care unit setting for these very purposes .'],\n",
              " ['O O O O O O O O B I I O B O B I O O B O',\n",
              "  'Various reported side effects of fentanyl administration include chest wall rigidity , hypotension , respiratory depression , and bradycardia .'],\n",
              " ['O O O O O B I I O O O O O O B O O O O O O O O O O O',\n",
              "  'Here , 2 cases of urinary bladder retention leading to renal pelvocalyceal dilatation mimicking hydronephrosis as a result of continuous infusion of fentanyl are reported .'],\n",
              " ['O B O O O O O O O O O O O O O',\n",
              "  'Fatal myeloencephalopathy due to accidental intrathecal vincristin administration : a report of two cases .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B I I O O O O O O O',\n",
              "  'We report on two fatal cases of accidental intrathecal vincristine instillation in a 5 - year old girl with recurrent acute lymphoblastic leucemia and a 57 - year old man'],\n",
              " ['O B I O', 'with lymphoblastic lymphoma .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'The girl died seven days , the man four weeks after intrathecal injection of vincristine .'],\n",
              " ['O O O O O O O O O O B I I I I I O O B O',\n",
              "  'Clinically , the onset was characterized by the signs of opistothonus , sensory and motor dysfunction and ascending paralysis .'],\n",
              " ['O O O O O O O O O O O O O O O O B I I I I O O O B I O O O O',\n",
              "  'Histological and immunohistochemical investigations ( HE - LFB , CD - 68 , Neurofilament ) revealed degeneration of myelin and axons as well as pseudocystic transformation in areas exposed to'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'vincristine , accompanied by secondary changes with numerous prominent macrophages .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'The clinical course and histopathological results of the two cases are presented .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'A review of all reported cases in the literature is given .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'A better controlled regimen for administering vincristine and intrathecal chemotherapy is recommended .'],\n",
              " ['B I O O B O O O O',\n",
              "  'Palpebral twitching in a depressed adolescent on citalopram .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'Current estimates suggest that between 0 . 4 % and 8 . 3 % of children and adolescents are affected by major depression .'],\n",
              " ['O O O O O O O O O O O O O O O O O O B I O O B I O O O O O O',\n",
              "  'We report a favorable response to treatment with citalopram by a 15 - year - old boy with major depression who exhibited palpebral twitching during his first 2 weeks of'],\n",
              " ['O O', 'treatment .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'This may have been a side effect of citalopram as it remitted with redistribution of doses .'],\n",
              " ['O O O O O O O O O', 'The 3 - week sulphasalazine syndrome strikes again .'],\n",
              " ['O O O O O O O O O O O B O B O B O B O O O O O O O O O O O O',\n",
              "  'A 34 - year - old lady developed a constellation of dermatitis , fever , lymphadenopathy and hepatitis , beginning on the 17th day of a course of oral sulphasalazine'],\n",
              " ['O O O O B I O', 'for sero - negative rheumatoid arthritis .'],\n",
              " ['O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O',\n",
              "  'Cervical and inguinal lymph node biopsies showed the features of severe necrotising lymphadenitis , associated with erythrophagocytosis and prominent eosinophilic infiltrates , without viral inclusion bodies , suggestive of an'],\n",
              " ['B I I O O O O O O B I I I O O O O O O O O O O O O O O O O O',\n",
              "  'adverse drug reaction . A week later , fulminant drug - induced hepatitis , associated with the presence of anti - nuclear autoantibodies ( but not with other markers of'],\n",
              " ['B O O O O O B I I I O B O O O',\n",
              "  'autoimmunity ) , and accompanied by multi - organ failure and sepsis , supervened .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B I I O O O B O O',\n",
              "  'She subsequently died some 5 weeks after the commencement of her drug therapy . Post - mortem examination showed evidence of massive hepatocellular necrosis , acute hypersensitivity myocarditis , focal'],\n",
              " ['O O O O B O O B I I O O O O O B O',\n",
              "  'acute tubulo - interstitial nephritis and extensive bone marrow necrosis , with no evidence of malignancy .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called \" 3 - week sulphasalazine syndrome \" ,'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'a rare , but often fatal , immunoallergic reaction to sulphasalazine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O',\n",
              "  'Intravenous administration of prochlorperazine by 15 - minute infusion versus 2 - minute bolus does not affect the incidence of akathisia : a prospective , randomized , controlled trial .'],\n",
              " ['O O O O O O O O O O B O O O O O O O O O O O O O O O O O',\n",
              "  'STUDY OBJECTIVE : We sought to compare the rate of akathisia after administration of intravenous prochlorperazine as a 2 - minute bolus or 15 - minute infusion .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : We conducted a prospective , randomized , double - blind study in the emergency department of a central - city teaching hospital .'],\n",
              " ['O O O O O O O O O O B O B O O B O O O O O',\n",
              "  'Patients aged 18 years or older treated with prochlorperazine for headache , nausea , or vomiting were eligible for inclusion .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Study participants were randomized to receive 10 mg of prochlorperazine administered intravenously by means of 2 - minute push ( bolus group ) or 10 mg diluted in 50 mL'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'of normal saline solution administered by means of intravenous infusion during a 15 - minute period ( infusion group ) .'],\n",
              " ['O O O O O O O O O O B O O O O O O',\n",
              "  'The main outcome was the number of study participants experiencing akathisia within 60 minutes of administration .'],\n",
              " ['O O O O O O O O O O O B O O O O O O O O O O O O B O O O O O',\n",
              "  'Akathisia was defined as either a spontaneous report of restlessness or agitation or a change of 2 or more in the patient - reported akathisia rating scale and a change'],\n",
              " ['O O O O O O O O O B O O O',\n",
              "  'of at least 1 in the investigator - observed akathisia rating scale .'],\n",
              " ['O O O B O B O O O O O O O O O O O',\n",
              "  'The intensity of headache and nausea was measured with a 100 - mm visual analog scale .'],\n",
              " ['O O O O O O O O', 'RESULTS : One hundred patients were enrolled .'],\n",
              " ['O O O O O O O O O',\n",
              "  'One study participant was excluded after protocol violation .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O B O',\n",
              "  'Seventy - three percent ( 73 / 99 ) of the study participants were treated for headache and 70 % ( 70 / 99 ) for nausea .'],\n",
              " ['O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O',\n",
              "  'In the bolus group , 26 . 0 % ( 13 / 50 ) had akathisia compared with 32 . 7 % ( 16 / 49 ) in the infusion'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'group ( Delta = - 6 . 7 % ; 95 % confidence interval [ CI ] - 24 . 6 % to 11 . 2 % ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O',\n",
              "  'The difference between the bolus and infusion groups in the percentage of participants who saw a 50 % reduction in their headache intensity within 30 minutes was 11 . 8'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  '% ( 95 % CI - 9 . 6 % to 33 . 3 % ) .'],\n",
              " ['O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O',\n",
              "  'The difference in the percentage of patients with a 50 % reduction in their nausea was 12 . 6 % ( 95 % CI - 4 . 6 % to'],\n",
              " ['O O O O O O', '29 . 8 % ) .'],\n",
              " ['O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O',\n",
              "  'CONCLUSION : A 50 % reduction in the incidence of akathisia when prochlorperazine was administered by means of 15 - minute intravenous infusion versus a 2 - minute intravenous push'],\n",
              " ['O O O O', 'was not detected .'],\n",
              " ['O O O O O O O O B O B O O O O O O O O O O O O O O O O O O O',\n",
              "  'The efficacy of prochlorperazine in the treatment of headache and nausea likewise did not appear to be affected by the rate of administration , although no formal statistical comparisons were'],\n",
              " ['O O', 'made .'],\n",
              " ['O O O O B O O O O O O B O O',\n",
              "  'Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice .'],\n",
              " ['O O O O O O O O O O B O B O O O O O O O O O O B O O O B I O',\n",
              "  'Highly active antiretroviral therapy ( HAART ) is implicated in cardiomyopathy ( CM ) and in elevated plasma lactate ( LA ) in AIDS through mechanisms of mitochondrial dysfunction .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O',\n",
              "  'To determine mitochondrial events from HAART in vivo , 8 - week - old hemizygous transgenic AIDS mice ( NL4 - 3Delta gag / pol ; TG ) and wild'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '- type FVB / n littermates were treated with the HAART combination of zidovudine , lamivudine , and indinavir or vehicle control for 10 days or 35 days .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O',\n",
              "  'At termination of the experiments , mice underwent echocardiography , quantitation of abundance of molecular markers of CM ( ventricular mRNA encoding atrial natriuretic factor [ ANF ] and sarcoplasmic'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'calcium ATPase [ SERCA2 ] ) , and determination of plasma LA .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'Myocardial histologic features were analyzed semiquantitatively and results were confirmed by transmission electron microscopy .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'After 35 days in the TG + HAART cohort , left ventricular mass increased 160 % by echocardiography .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'Molecularly , ANF mRNA increased 250 % and SERCA2 mRNA decreased 57 % .'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  'Biochemically , LA was elevated ( 8 . 5 + / - 2 . 0 mM ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'Pathologically , granular cytoplasmic changes were found in cardiac myocytes , indicating enlarged , damaged mitochondria .'],\n",
              " ['O O O O O', 'Findings were confirmed ultrastructurally .'],\n",
              " ['O O O O O O O O', 'No changes were found in other cohorts .'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  'After 10 days , only ANF was elevated , and only in the TG + HAART cohort .'],\n",
              " ['O O O O O O O B O O O O B O O O',\n",
              "  'Results show that cumulative HAART caused mitochondrial CM with elevated LA in AIDS transgenic mice .'],\n",
              " ['O O O O O O O O O O O O O O O B I O O O O O O O O O O O',\n",
              "  'A Phase II trial of cisplatin plus WR - 2721 ( amifostine ) for metastatic breast carcinoma : an Eastern Cooperative Oncology Group Study ( E8188 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'BACKGROUND : Cisplatin has minimal antitumor activity when used as second - or third - line treatment of metastatic breast carcinoma .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Older reports suggest an objective response rate of 8 % when 60 - 120 mg / m2 of cisplatin is administered every 3 - 4 weeks .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O B O B O',\n",
              "  'Although a dose - response effect has been observed with cisplatin , the dose - limiting toxicities associated with cisplatin ( e . g . , nephrotoxicity , ototoxicity ,'],\n",
              " ['O B O O O O O O O O O B I O',\n",
              "  'and neurotoxicity ) have limited its use as a treatment for breast carcinoma .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'WR - 2721 or amifostine initially was developed to protect military personnel in the event of nuclear war .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Amifostine subsequently was shown to protect normal tissues from the toxic effects of alkylating agents and cisplatin without decreasing the antitumor effect of the chemotherapy .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O B O O B O O O',\n",
              "  'Early trials of cisplatin and amifostine also suggested that the incidence and severity of cisplatin - induced nephrotoxicity , ototoxicity , and neuropathy were reduced .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O',\n",
              "  'METHODS : A Phase II study of the combination of cisplatin plus amifostine was conducted in patients with progressive metastatic breast carcinoma who had received one , but not more'],\n",
              " ['O O O O O O O O O',\n",
              "  'than one , chemotherapy regimen for metastatic disease .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'Patients received amifostine , 910 mg / m2 intravenously over 15 minutes .'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  'After completion of the amifostine infusion , cisplatin 120 mg / m2 was administered over 30 minutes .'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'Intravenous hydration and mannitol was administered before and after cisplatin .'],\n",
              " ['O O O O O O O O O O',\n",
              "  'Treatment was administered every 3 weeks until disease progression .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'RESULTS : Forty - four patients were enrolled in the study of which 7 ( 16 % ) were ineligible .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'A median of 2 cycles of therapy was administered to the 37 eligible patients .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'Six partial responses were observed for an overall response rate of 16 % .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'Most patients ( 57 % ) stopped treatment because of disease progression .'],\n",
              " ['B I O O O O O O O O',\n",
              "  'Neurologic toxicity was reported in 52 % of patients .'],\n",
              " ['O O O O O B O O O O O O O O',\n",
              "  'Seven different life - threatening toxicities were observed in patients while receiving treatment .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'CONCLUSIONS : The combination of cisplatin and amifostine in this study resulted in an overall response rate of 16 % .'],\n",
              " ['O O B O O O O O B O O O O O O O O O O O O O O O O',\n",
              "  'Neither a tumor - protective effect nor reduced toxicity to normal tissues was observed with the addition of amifostine to cisplatin in this trial .'],\n",
              " ['O O O O O O B I O',\n",
              "  'Oral contraceptives and the risk of myocardial infarction .'],\n",
              " ['O O O O O O O O O O O O O O B I O O O O O O O O O O O O',\n",
              "  'BACKGROUND : An association between the use of oral contraceptives and the risk of myocardial infarction has been found in some , but not all , studies .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'We investigated this association , according to the type of progestagen included in third - generation ( i . e . , desogestrel or gestodene ) and second - generation'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '( i . e . , levonorgestrel ) oral contraceptives , the dose of estrogen , and the presence or absence of prothrombotic mutations METHODS : In a nationwide ,'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O',\n",
              "  'population - based , case - control study , we identified and enrolled 248 women 18 through 49 years of age who had had a first myocardial infarction between 1990'],\n",
              " ['O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O',\n",
              "  'and 1995 and 925 control women who had not had a myocardial infarction and who were matched for age , calendar year of the index event , and area of'],\n",
              " ['O O', 'residence .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'Subjects supplied information on oral - contraceptive use and major cardiovascular risk factors .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'An analysis for factor V Leiden and the G20210A mutation in the prothrombin gene was conducted in 217 patients and 763 controls RESULTS : The odds ratio for'],\n",
              " ['B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'myocardial infarction among women who used any type of combined oral contraceptive , as compared with nonusers , was 2 . 0 ( 95 percent confidence interval , 1 .'],\n",
              " ['O O O O O O O', '5 to 2 . 8 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The adjusted odds ratio was 2 . 5 ( 95 percent confidence interval , 1 . 5 to 4 . 1 ) among women who used second - generation oral'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'contraceptives and 1 . 3 ( 95 percent confidence interval , 0 . 7 to 2 . 5 ) among those who used third - generation oral contraceptives .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Among women who used oral contraceptives , the odds ratio was 2 . 1 ( 95 percent confidence interval , 1 . 5 to 3 . 0 ) for those'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'without a prothrombotic mutation and 1 . 9 ( 95 percent confidence interval , 0 . 6 to 5 . 5 ) for those with a mutation CONCLUSIONS : The'],\n",
              " ['O O B I O O O O O O O O O O O O',\n",
              "  'risk of myocardial infarction was increased among women who used second - generation oral contraceptives .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The results with respect to the use of third - generation oral contraceptives were inconclusive but suggested that the risk was lower than the risk associated with second - generation'],\n",
              " ['O O O', 'oral contraceptives .'],\n",
              " ['O O O B I O O O O O O O O O O O O O O O O O',\n",
              "  'The risk of myocardial infarction was similar among women who used oral contraceptives whether or not they had a prothrombotic mutation .'],\n",
              " ['B I I I I O B O O O O O O O O O O O O O O O O O O O O',\n",
              "  'End - stage renal disease ( ESRD ) after orthotopic liver transplantation ( OLTX ) using calcineurin - based immunotherapy : risk of development and treatment .'],\n",
              " ['O O O O O O O O O O O O O B O',\n",
              "  'BACKGROUND : The calcineurin inhibitors cyclosporine and tacrolimus are both known to be nephrotoxic .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'Their use in orthotopic liver transplantation ( OLTX ) has dramatically improved success rates .'],\n",
              " ['O O O O O O O O O O O O O O O O O B I I I I O B O O',\n",
              "  'Recently , however , we have had an increase of patients who are presenting after OLTX with end - stage renal disease ( ESRD ) .'],\n",
              " ['O O O O O O O O O B O B I I O B O O O O O',\n",
              "  'This retrospective study examines the incidence and treatment of ESRD and chronic renal failure ( CRF ) in OLTX patients .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : Patients receiving an OLTX only from June 1985 through December of 1994 who survived 6 months postoperatively were studied ( n = 834 ) .'],\n",
              " ['O O O O O O O O O O',\n",
              "  'Our prospectively collected database was the source of information .'],\n",
              " ['O O O O O O O O O O B O B O O O O O B O O O O O O O O O O O',\n",
              "  'Patients were divided into three groups : Controls , no CRF or ESRD , n = 748 ; CRF , sustained serum creatinine > 2 . 5 mg / dl'],\n",
              " ['O O O O O O B O O O O O', ', n = 41 ; and ESRD , n = 45 .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O O O O O O O B O',\n",
              "  'Groups were compared for preoperative laboratory variables , diagnosis , postoperative variables , survival , type of ESRD therapy , and survival from onset of ESRD .'],\n",
              " ['O O O O O O O O O O O O B I O O O O O O B O O O O O B O O O',\n",
              "  'RESULTS : At 13 years after OLTX , the incidence of severe renal dysfunction was 18 . 1 % ( CRF 8 . 6 % and ESRD 9 . 5'],\n",
              " ['O O O', '% ) .'],\n",
              " ['O O O O O B O B O O O O O O O O O O O O O O B I O O O O O O',\n",
              "  'Compared with control patients , CRF and ESRD patients had higher preoperative serum creatinine levels , a greater percentage of patients with hepatorenal syndrome , higher percentage requirement for dialysis'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'in the first 3 months postoperatively , and a higher 1 - year serum creatinine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Multivariate stepwise logistic regression analysis using preoperative and postoperative variables identified that an increase of serum creatinine compared with average at 1 year , 3 months , and 4 weeks'],\n",
              " ['O O O O O O O O O B O B O O O O O O O O O O O O O O O O O O',\n",
              "  'postoperatively were independent risk factors for the development of CRF or ESRD with odds ratios of 2 . 6 , 2 . 2 , and 1 . 6 , respectively'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O',\n",
              "  'Overall survival from the time of OLTX was not significantly different among groups , but by year 13 , the survival of the patients who had ESRD was only 28'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  '. 2 % compared with 54 . 6 % in the control group .'],\n",
              " ['O O B O O O O O O O O O B O O O O O O O O O O O O O O O O O',\n",
              "  'Patients developing ESRD had a 6 - year survival after onset of ESRD of 27 % for the patients receiving hemodialysis versus 71 . 4 % for the patients developing'],\n",
              " ['B O O O O O O', 'ESRD who subsequently received kidney transplants .'],\n",
              " ['O O O O O O O O O O O O O B O B O O O O O',\n",
              "  'CONCLUSIONS : Patients who are more than 10 years post - OLTX have CRF and ESRD at a high rate .'],\n",
              " ['O O O B O O O O O O O O O O O O',\n",
              "  'The development of ESRD decreases survival , particularly in those patients treated with dialysis only .'],\n",
              " ['O O O B O O O O O O O O O O O O O O O O B I O',\n",
              "  'Patients who develop ESRD have a higher preoperative and 1 - year serum creatinine and are more likely to have hepatorenal syndrome .'],\n",
              " ['O O O O O O O O O O O O O O O O O O B O B O',\n",
              "  'However , an increase of serum creatinine at various times postoperatively is more predictive of the development of CRF or ESRD .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'New strategies for long - term immunosuppression may be needed to decrease this complication .'],\n",
              " ['B I O O O O O O O O O O O O',\n",
              "  'Epileptic seizures following cortical application of fibrin sealants containing tranexamic acid in rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'BACKGROUND : Fibrin sealants ( FS ) derived from human plasma are frequently used in neurosurgery .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'In order to increase clot stability , FS typically contain aprotinin , a natural fibrinolysis inhibitor .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Recently , synthetic fibrinolysis inhibitors such as tranexamic acid ( tAMCA ) have been considered as substitutes for aprotinin .'],\n",
              " ['O O O O O O O O B I O',\n",
              "  'However , tAMCA has been shown to cause epileptic seizures .'],\n",
              " ['O O O O O O O O B O O O O O O O',\n",
              "  'We wanted to study whether tAMCA retains its convulsive action if incorporated into a FS .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHOD : FS containing aprotinin or different concentrations of tAMCA ( 0 . 5 - 47 . 5 mg / ml ) were applied to the pial surface of the'],\n",
              " ['O O O O O', 'cortex of anaesthetized rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The response of the animals was evaluated using electroencephalography and by monitoring the clinical behaviour during and after recovery from anaesthesia .'],\n",
              " ['O O O O O O O O O O O O O O B O O',\n",
              "  'FINDINGS : FS containing tAMCA caused paroxysmal brain activity which was associated with distinct convulsive behaviours .'],\n",
              " ['O O O O B O O O O O O O',\n",
              "  'The degree of these seizures increased with increasing concentration of tAMCA .'],\n",
              " ['O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O',\n",
              "  'Thus , FS containing 47 . 5 mg / ml tAMCA evoked generalized seizures in all tested rats ( n = 6 ) while the lowest concentration of tAMCA ('],\n",
              " ['O O O O O O O O O O O O O O O B O O O O O O O',\n",
              "  '0 . 5 mg / ml ) only evoked brief episodes of jerk - correlated convulsive potentials in 1 of 6 rats .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'In contrast , FS containing aprotinin did not evoke any paroxysmal activity .'],\n",
              " ['O O O O O O B O O O O',\n",
              "  'INTERPRETATION : Tranexamic acid retains its convulsive action within FS .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Thus , use of FS containing tAMCA for surgery within or close to the CNS may pose a substantial risk to the patient .'],\n",
              " ['O O O B O O O O O O O O O O O O O O O O O O B O B O',\n",
              "  'Sequential observations of exencephaly and subsequent morphological changes by mouse exo utero development system : analysis of the mechanism of transformation from exencephaly to anencephaly .'],\n",
              " ['B O O O O O O B O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Anencephaly has been suggested to develop from exencephaly ; however , there is little direct experimental evidence to support this , and the mechanism of transformation remains unclear .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'We examined this theory using the exo utero development system that allows direct and sequential observations of mid - to late - gestation mouse embryos .'],\n",
              " ['O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'We observed the exencephaly induced by 5 - azacytidine at embryonic day 13 . 5 ( E13 . 5 ) , let the embryos develop exo utero until E18 .'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  '5 , and re - observed the same embryos at E18 . 5 .'],\n",
              " ['O O O O O O O B O B O',\n",
              "  'We confirmed several cases of transformation from exencephaly to anencephaly .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O O O',\n",
              "  'However , in many cases , the exencephalic brain tissue was preserved with more or less reduction during this period .'],\n",
              " ['O O O O O O O O O B O O O O O O B O O O O O O O O O O O O O',\n",
              "  'To analyze the transformation patterns , we classified the exencephaly by size and shape of the exencephalic tissue into several types at E13 . 5 and E18 . 5 .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O O B O O O O O O O O O',\n",
              "  'It was found that the transformation of exencephalic tissue was not simply size - dependent , and all cases of anencephaly at E18 . 5 resulted from embryos with a'],\n",
              " ['O O O B O O O O O O', 'large amount of exencephalic tissue at E13 . 5 .'],\n",
              " ['O O O O O O B O O O O O O B O O O O O O O O O O O B O O O O',\n",
              "  'Microscopic observation showed the configuration of exencephaly at E13 . 5 , frequent hemorrhaging and detachment of the neural plate from surface ectoderm in the exencephalic head at E15 .'],\n",
              " ['O O O O O O O O O B O O O O O O',\n",
              "  '5 , and multiple modes of reduction in the exencephalic tissue at E18 . 5 .'],\n",
              " ['O O O O O O O O O O O O O O O B O O',\n",
              "  'From observations of the vasculature , altered distribution patterns of vessels were identified in the exencephalic head .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O O B I O O O B O O O O',\n",
              "  'These findings suggest that overgrowth of the exencephalic neural tissue causes the altered distribution patterns of vessels , subsequent peripheral circulatory failure and / or hemorrhaging in various parts of'],\n",
              " ['O B O O O O O O O O O O O O O B O B O',\n",
              "  'the exencephalic head , leading to the multiple modes of tissue reduction during transformation from exencephaly to anencephaly .'],\n",
              " ['O O O O O O O O O B I O O O',\n",
              "  '99mTc - glucarate for detection of isoproterenol - induced myocardial infarction in rats .'],\n",
              " ['B O O O O O O O O O O O O B I O',\n",
              "  'Infarct - avid radiopharmaceuticals are necessary for rapid and timely diagnosis of acute myocardial infarction .'],\n",
              " ['O O O O O O B O O O O O O O O O O O O O',\n",
              "  'The animal model used to produce infarction implies artery ligation but chemical induction can be easily obtained with isoproterenol .'],\n",
              " ['O O B O O O O O O O O O O O O O O O O O',\n",
              "  'A new infarct - avid radiopharmaceutical based on glucaric acid was prepared in the hospital radiopharmacy of the INCMNSZ .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  '99mTc - glucarate was easy to prepare , stable for 96 h and was used to study its biodistribution in rats with isoproterenol - induced acute myocardial infarction .'],\n",
              " ['O O O O O O O O B O O O O O O',\n",
              "  'Histological studies demonstrated that the rats developed an infarct 18 h after isoproterenol administration .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'The rat biodistribution studies showed a rapid blood clearance via the kidneys .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Thirty minutes after 99mTc - glucarate administration the standardised heart uptake value S ( h ) UV was 4 . 7 in infarcted rat heart which is six times more'],\n",
              " ['O O O O O', 'than in normal rats .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'ROIs drawn over the gamma camera images showed a ratio of 4 . 4 .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The high image quality suggests that high contrast images can be obtained in humans and the 96 h stability makes it an ideal agent to detect , in patients ,'],\n",
              " ['O B I O', 'early cardiac infarction .'],\n",
              " ['O O O O B O', 'Bupropion ( Zyban ) toxicity .'],\n",
              " ['O O O O O O O O O O',\n",
              "  'Bupropion is a monocyclic antidepressant structurally related to amphetamine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Zyban , a sustained - release formulation of bupropion hydrochloride , was recently released in Ireland , as a smoking cessation aid .'],\n",
              " ['O O O O O O O O O O O O B O O O O O O O O O O O',\n",
              "  \"In the initial 6 months since it ' s introduction , 12 overdose cases have been reported to The National Poisons Information Centre .\"],\n",
              " ['O O O O O B O', '8 patients developed symptoms of toxicity .'],\n",
              " ['O O O B O O O B O B O',\n",
              "  'Common features included tachycardia , drowsiness , hallucinations and convulsions .'],\n",
              " ['O O O O B I O O O O O O O O O B I O',\n",
              "  'Two patients developed severe cardiac arrhythmias , including one patient who was resuscitated following a cardiac arrest .'],\n",
              " ['O O O O O O', 'All patients recovered without sequelae .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'We report a case of a 31 year old female who required admission to the Intensive Care Unit for ventilation and full supportive therapy , following ingestion of 13 .'],\n",
              " ['O O O', '5g bupropion .'],\n",
              " ['O B O O O O O O O B O O O O O O',\n",
              "  'Recurrent seizures were treated with diazepam and broad complex tachycardia was successfully treated with adenosine .'],\n",
              " ['O O O B I I I O B O',\n",
              "  'Zyban caused significant neurological and cardiovascular toxicity in overdose .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'The potential toxic effects should be considered when prescribing it as a smoking cessation aid .'],\n",
              " ['O O O O O O O O O O B O',\n",
              "  'GLEPP1 receptor tyrosine phosphatase ( Ptpro ) in rat PAN nephrosis .'],\n",
              " ['O O O O O O O', 'A marker of acute podocyte injury .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Glomerular epithelial protein 1 ( GLEPP1 ) is a podocyte receptor membrane protein tyrosine phosphatase located on the apical cell membrane of visceral glomerular epithelial cell and foot processes .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'This receptor plays a role in regulating the structure and function of podocyte foot process .'],\n",
              " ['O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O',\n",
              "  'To better understand the utility of GLEPP1 as a marker of glomerular injury , the amount and distribution of GLEPP1 protein and mRNA were examined by immunohistochemistry , Western blot'],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  'and RNase protection assay in a model of podocyte injury in the rat .'],\n",
              " ['O O B O O O O O O O O O O O O O O O O O O O',\n",
              "  'Puromycin aminonucleoside nephrosis was induced by single intraperitoneal injection of puromycin aminonucleoside ( PAN , 20 mg / 100g BW ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Tissues were analyzed at 0 , 5 , 7 , 11 , 21 , 45 , 80 and 126 days after PAN injection so as to include both the acute'],\n",
              " ['O O B O O O O O O O O O O O O O O O O B O O B O O O O O O O',\n",
              "  'phase of proteinuria associated with foot process effacement ( days 5 - 11 ) and the chronic phase of proteinuria associated with glomerulosclerosis ( days 45 - 126 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'At day 5 , GLEPP1 protein and mRNA were reduced from the normal range ( 265 . 2 + / - 79 . 6 x 10 ( 6 ) moles'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '/ glomerulus and 100 % ) to 15 % of normal ( 41 . 8 + / - 4 . 8 x 10 ( 6 ) moles / glomerulus ,'],\n",
              " ['O O O O O O O', 'p < 0 . 005 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'This occurred in association with an increase in urinary protein content from 1 . 8 + / - 1 to 99 . 0 + / - 61 mg / day'],\n",
              " ['O O O O O O O O', '( p < 0 . 001 ) .'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'In contrast , podocalyxin did not change significantly at this time .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'By day 11 , GLEPP1 protein and mRNA had begun to return towards baseline .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'By day 45 - 126 , at a time when glomerular scarring was present , GLEPP1 was absent from glomerulosclerotic areas although the total glomerular content of GLEPP1 was not'],\n",
              " ['O O O O', 'different from normal .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'We conclude that GLEPP1 expression , unlike podocalyxin , reflects podocyte injury induced by PAN .'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'GLEPP1 expression may be a useful marker of podocyte injury .'],\n",
              " ['O O O O O O O O O O O B I O',\n",
              "  'Antithymocyte globulin in the treatment of D - penicillamine - induced aplastic anemia .'],\n",
              " ['O O O O O O O O B I O O O O O O O O O',\n",
              "  'A patient who received antithymocyte globulin therapy for aplastic anemia due to D - penicillamine therapy is described .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Bone marrow recovery and peripheral blood recovery were complete 1 month and 3 months , respectively , after treatment , and blood transfusion or other therapies were not necessary in'],\n",
              " ['O O O O O O O O O O O', 'a follow - up period of more than 2 years .'],\n",
              " ['O O O O O O O O O O O O O O O B I O',\n",
              "  'Use of antithymocyte globulin may be the optimal treatment of D - penicillamine - induced aplastic anemia .'],\n",
              " ['O O O O O O B O O O O',\n",
              "  'Metamizol potentiates morphine antinociception but not constipation after chronic treatment .'],\n",
              " ['O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'This work evaluates the antinociceptive and constipating effects of the combination of 3 . 2 mg / kg s . c . morphine with 177 . 8 mg / kg'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  's . c . metamizol in acutely and chronically treated ( once a day for 12 days ) rats .'],\n",
              " ['O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O',\n",
              "  'On the 13th day , antinociceptive effects were assessed using a model of inflammatory nociception , pain - induced functional impairment model , and the charcoal meal test was used'],\n",
              " ['O O O O O O', 'to evaluate the intestinal transit .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Simultaneous administration of morphine with metamizol resulted in a markedly antinociceptive potentiation and an increasing of the duration of action after a single ( 298 + / - 7 vs'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '. 139 + / - 36 units area ( ua ) ; P < 0 . 001 ) and repeated administration ( 280 + / - 17 vs . 131'],\n",
              " ['O O O O O O O O O O O O O', '+ / - 22 ua ; P < 0 . 001 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Antinociceptive effect of morphine was reduced in chronically treated rats ( 39 + / - 10 vs . 18 + / - 5 au ) while the combination - induced'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'antinociception was remained similar as an acute treatment ( 298 + / - 7 vs . 280 + / - 17 au ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Acute antinociceptive effects of the combination were partially prevented by 3 . 2 mg / kg naloxone s . c .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '( P < 0 . 05 ) , suggesting the partial involvement of the opioidergic system in the synergism observed .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In independent groups , morphine inhibited the intestinal transit in 48 + / - 4 % and 38 + / - 4 % after acute and chronic treatment , respectively'],\n",
              " ['O O O O O O O O O B O O',\n",
              "  ', suggesting that tolerance did not develop to the constipating effects .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'The combination inhibited intestinal transit similar to that produced by morphine regardless of the time of treatment , suggesting that metamizol did not potentiate morphine - induced constipation .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'These findings show a significant interaction between morphine and metamizol in chronically treated rats , suggesting that this combination could be useful for the treatment of chronic pain .'],\n",
              " ['O B O O B O', 'Ifosfamide encephalopathy presenting with asterixis .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'CNS toxic effects of the antineoplastic agent ifosfamide ( IFX ) are frequent and include a variety of neurological symptoms that can limit drug use .'],\n",
              " ['O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O',\n",
              "  'We report a case of a 51 - year - old man who developed severe , disabling negative myoclonus of the upper and lower extremities after the infusion of ifosfamide'],\n",
              " ['O B O', 'for plasmacytoma .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'He was awake , revealed no changes of mental status and at rest there were no further motor symptoms .'],\n",
              " ['O O O O O O O O O O O B I I I I O B I O',\n",
              "  'Cranial magnetic resonance imaging and extensive laboratory studies failed to reveal structural lesions of the brain and metabolic abnormalities .'],\n",
              " ['O O O O O O O O O O O O O O O B O',\n",
              "  'An electroencephalogram showed continuous , generalized irregular slowing with admixed periodic triphasic waves indicating symptomatic encephalopathy .'],\n",
              " ['O O O O O O O O O O O B O O O',\n",
              "  'The administration of ifosfamide was discontinued and within 12 h the asterixis resolved completely .'],\n",
              " ['O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In the patient described , the presence of asterixis during infusion of ifosfamide , normal laboratory findings and imaging studies and the resolution of symptoms following the discontinuation of the'],\n",
              " ['O O O O B O O O O O O O O',\n",
              "  'drug suggest that negative myoclonus is associated with the use of IFX .'],\n",
              " ['O O O O O O O O O O O O B O O O O O O O',\n",
              "  'Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine - induced anemia and in bone marrow endothelial cells .'],\n",
              " ['O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Azidothymidine ( AZT ) - induced anemia in mice can be reversed by the administration of IGF - IL - 3 ( fusion protein of insulin - like growth factor'],\n",
              " ['O O O O O O O O O O', 'II ( IGF II ) and interleukin 3 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Although interleukin 3 ( IL - 3 ) and erythropoietin ( EPO ) are known to act synergistically on hematopoietic cell proliferation in vitro , injection of IGF - IL'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '- 3 and EPO in AZT - treated mice resulted in a reduction of red cells and an increase of plasma EPO levels as compared to animals treated with IGF'],\n",
              " ['O O O O O O O O', '- IL - 3 or EPO alone .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'We tested the hypothesis that the antagonistic effect of IL - 3 and EPO on erythroid cells may be mediated by endothelial cells .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Bovine liver erythroid cells were cultured on monolayers of human bone marrow endothelial cells previously treated with EPO and IGF - IL - 3 .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'There was a significant reduction of thymidine incorporation into both erythroid and endothelial cells in cultures pre - treated with IGF - IL - 3 and EPO .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Endothelial cell culture supernatants separated by ultrafiltration and ultracentrifugation from cells treated with EPO and IL - 3 significantly reduced thymidine incorporation into erythroid cells as compared to identical fractions'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'obtained from the media of cells cultured with EPO alone .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'These results suggest that endothelial cells treated simultaneously with EPO and IL - 3 have a negative effect on erythroid cell production .'],\n",
              " ['O O O O O O O O O O O O B O O O O B O O O O O O',\n",
              "  'The relationship between hippocampal acetylcholine release and cholinergic convulsant sensitivity in withdrawal seizure - prone and withdrawal seizure - resistant selected mouse lines .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'BACKGROUND : The septo - hippocampal cholinergic pathway has been implicated in epileptogenesis , and genetic factors influence the response to cholinergic agents , but limited data are available on'],\n",
              " ['O O O O O O O', 'cholinergic involvement in alcohol withdrawal severity .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Thus , the relationship between cholinergic activity and responsiveness and alcohol withdrawal was investigated in a genetic animal model of ethanol withdrawal severity .'],\n",
              " ['O O O O O O O O O O O O O B O O O O O O O O O O O O O',\n",
              "  'METHODS : Cholinergic convulsant sensitivity was examined in alcohol - na ve Withdrawal Seizure - Prone ( WSP ) and - Resistant ( WSR ) mice .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O',\n",
              "  'Animals were administered nicotine , carbachol , or neostigmine via timed tail vein infusion , and the latencies to onset of tremor and clonus were recorded and converted to threshold'],\n",
              " ['O O', 'dose .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'We also used microdialysis to measure basal and potassium - stimulated acetylcholine ( ACh ) release in the CA1 region of the hippocampus .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'Potassium was applied by reverse dialysis twice , separated by 75 min .'],\n",
              " ['O O O O O O O O O O O B O',\n",
              "  'Hippocampal ACh also was measured during testing for handling - induced convulsions .'],\n",
              " ['O O O O O B O O O O O O O O O O O O O O O O O O',\n",
              "  'RESULTS : Sensitivity to several convulsion endpoints induced by nicotine , carbachol , and neostigmine were significantly greater in WSR versus WSP mice .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In microdialysis experiments , the lines did not differ in basal release of ACh , and 50 mM KCl increased ACh output in both lines of mice .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'However , the increase in release of ACh produced by the first application of KCl was 2 - fold higher in WSP versus WSR mice .'],\n",
              " ['O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O',\n",
              "  'When hippocampal ACh was measured during testing for handling - induced convulsions , extracellular ACh was significantly elevated ( 192 % ) in WSP mice , but was nonsignificantly elevated'],\n",
              " ['O O O O O O O O', '( 59 % ) in WSR mice .'],\n",
              " ['O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O',\n",
              "  'CONCLUSIONS : These results suggest that differences in cholinergic activity and postsynaptic sensitivity to cholinergic convulsants may be associated with ethanol withdrawal severity and implicate cholinergic mechanisms in alcohol withdrawal'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O O O O O B O O O O O O O O O O O O O O O O O',\n",
              "  'Specifically , WSP mice may have lower sensitivity to cholinergic convulsants compared with WSR because of postsynaptic receptor desensitization brought on by higher activity of cholinergic neurons .'],\n",
              " ['O O O B I O O O O O O O O O O O',\n",
              "  'Capsaicin - induced muscle pain alters the excitability of the human jaw - stretch reflex .'],\n",
              " ['O O O O B I O O O O O O O O O B I O O O O O O O',\n",
              "  'The pathophysiology of painful temporomandibular disorders is not fully understood , but evidence suggests that muscle pain modulates motor function in characteristic ways .'],\n",
              " ['O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O',\n",
              "  'This study tested the hypothesis that activation of nociceptive muscle afferent fibers would be linked to an increased excitability of the human jaw - stretch reflex and whether this process'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'would be sensitive to length and velocity of the stretch .'],\n",
              " ['O O O O O O O O O O O O O O B O O O O O',\n",
              "  'Capsaicin ( 10 micro g ) was injected into the masseter muscle to induce pain in 11 healthy volunteers .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Short - latency reflex responses were evoked in the masseter and temporalis muscles by a stretch device with different velocities and displacements before , during , and after the'],\n",
              " ['B O', 'pain .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The normalized reflex amplitude increased with an increase in velocity at a given displacement , but remained constant with different displacements at a given velocity .'],\n",
              " ['O O O O O O O O B O O O O O O O O B I O',\n",
              "  'The normalized reflex amplitude was significantly higher during pain , but only at faster stretches in the painful muscle .'],\n",
              " ['O O O O O O O O B I O O O O O O O O O O',\n",
              "  'Increased sensitivity of the fusimotor system during acute muscle pain could be one likely mechanism to explain the findings .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O B I O O O',\n",
              "  'Effects of 5 - HT1B receptor ligands microinjected into the accumbal shell or core on the cocaine - induced locomotor hyperactivity in rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The present study was designed to examine the effect of 5 - HT1B receptor ligands microinjected into the subregions of the nucleus accumbens ( the shell and the core )'],\n",
              " ['O O B I O O O O O O',\n",
              "  'on the locomotor hyperactivity induced by cocaine in rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Male Wistar rats were implanted bilaterally with cannulae into the accumbens shell or core , and then were locally injected with GR 55562 ( an antagonist of 5 - HT1B'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'receptors ) or CP 93129 ( an agonist of 5 - HT1B receptors ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Given alone to any accumbal subregion , GR 55562 ( 0 . 1 - 10 microg / side ) or CP 93129 ( 0 . 1 - 10 microg /'],\n",
              " ['O O O O O O O O O', 'side ) did not change basal locomotor activity .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'Systemic cocaine ( 10 mg / kg ) significantly increased the locomotor activity of rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'GR 55562 ( 0 . 1 - 10 microg / side ) , administered intra - accumbens shell prior to cocaine , dose - dependently attenuated the psychostimulant - induced'],\n",
              " ['B I O', 'locomotor hyperactivity .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Such attenuation was not found in animals which had been injected with GR 55562 into the accumbens core .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'When injected into the accumbens shell ( but not the core ) before cocaine , CP 93129 ( 0 . 1 - 10 microg / side ) enhanced the locomotor'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  'response to cocaine ; the maximum effect being observed after 10 microg / side of the agonist .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The later enhancement was attenuated after intra - accumbens shell treatment with GR 55562 ( 1 microg / side ) .'],\n",
              " ['O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Our findings indicate that cocaine induced hyperlocomotion is modified by 5 - HT1B receptor ligands microinjected into the accumbens shell , but not core , this modification consisting in inhibitory'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'and facilitatory effects of the 5 - HT1B receptor antagonist ( GR 55562 ) and agonist ( CP 93129 ) , respectively .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'In other words , the present results suggest that the accumbal shell 5 - HT1B receptors play a permissive role in the behavioural response to the psychostimulant .'],\n",
              " ['O O B I O O O O O O O O O O',\n",
              "  'Cocaine related chest pain : are we seeing the tip of an iceberg ?'],\n",
              " ['O O O O O O O O O O',\n",
              "  'The recreational use of cocaine is on the increase .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'The emergency nurse ought to be familiar with some of the cardiovascular consequences of cocaine use .'],\n",
              " ['O O O O O O O O O B I O O O O O O O O O O O O O O O O O',\n",
              "  'In particular , the tendency of cocaine to produce chest pain ought to be in the mind of the emergency nurse when faced with a young victim of'],\n",
              " ['B I O O O O O O O', 'chest pain who is otherwise at low risk .'],\n",
              " ['O O O B I O O O O O O O O O O O O',\n",
              "  'The mechanism of chest pain related to cocaine use is discussed and treatment dilemmas are discussed .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'Finally , moral issues relating to the testing of potential cocaine users will be addressed .'],\n",
              " ['O O O O O O O O O O O O O O O B O',\n",
              "  'Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine / caffeine in migraine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O',\n",
              "  'Rizatriptan is a selective 5 - HT ( 1B / 1D ) receptor agonist with rapid oral absorption and early onset of action in the acute treatment of migraine .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'This randomized double - blind crossover outpatient study assessed the preference for 1 rizatriptan 10 mg tablet to 2 ergotamine 1 mg / caffeine 100 mg tablets in 439 patients'],\n",
              " ['O O O B O O O O O',\n",
              "  'treating a single migraine attack with each therapy .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Of patients expressing a preference ( 89 . 1 % ) , more than twice as many preferred rizatriptan to ergotamine / caffeine ( 69 . 9 vs . 30'],\n",
              " ['O O O O O O O O O O O O O', '. 1 % , p < or = 0 . 001 ) .'],\n",
              " ['O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Faster relief of headache was the most important reason for preference , cited by 67 . 3 % of patients preferring rizatriptan and 54 . 2 % of patients who'],\n",
              " ['O O O O O', 'preferred ergotamine / caffeine .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O',\n",
              "  'The co - primary endpoint of being pain free at 2 h was also in favor of rizatriptan .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Forty - nine percent of patients were pain free 2 h after rizatriptan , compared with 24 . 3 % treated with ergotamine / caffeine ( p < or ='],\n",
              " ['O O O O O O O O O O O O O O',\n",
              "  '0 . 001 ) , rizatriptan being superior within 1 h of treatment .'],\n",
              " ['B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Headache relief at 2 h was 75 . 9 % for rizatriptan and 47 . 3 % for ergotamine / caffeine ( p < or = 0 . 001 )'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  ', with rizatriptan being superior to ergotamine / caffeine within 30 min of dosing .'],\n",
              " ['O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Almost 36 % of patients taking rizatriptan were pain free at 2 h and had no recurrence or need for additional medication within 24 h , compared to 20 %'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'of patients on ergotamine / caffeine ( p < or = 0 . 001 ) .'],\n",
              " ['O O O O O O O O O O O O O O O B O B O B O B O O O O O O O O',\n",
              "  'Rizatriptan was also superior to ergotamine / caffeine in the proportions of patients with no nausea , vomiting , phonophobia or photophobia and for patients with normal function 2 h'],\n",
              " ['O O O O O O O O O O O O O', 'after drug intake ( p < or = 0 . 001 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'More patients were ( completely , very or somewhat ) satisfied 2 h after treatment with rizatriptan ( 69 . 8 % ) than at 2 h after treatment with'],\n",
              " ['O O O O O O O O O O O O O O O O O O',\n",
              "  'ergotamine / caffeine ( 38 . 6 % , p < or = 0 . 001 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'Recurrence rates were 31 . 4 % with rizatriptan and 15 . 3 % with ergotamine / caffeine .'],\n",
              " ['O O O O O O O', 'Both active treatments were well tolerated .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O',\n",
              "  'The most common adverse events ( incidence > or = 5 % in one group ) after rizatriptan and ergotamine / caffeine , respectively , were dizziness ( 6 .'],\n",
              " ['O O O O O O O O B O O O O O O O O O O O B O O O O O O O O O',\n",
              "  '7 and 5 . 3 % ) , nausea ( 4 . 2 and 8 . 5 % ) and somnolence ( 5 . 5 and 2 . 3 %'],\n",
              " ['O O', ') .'],\n",
              " ['O B I I I O O O O O O O B O',\n",
              "  'Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas .'],\n",
              " ['O O B O O B I O O O O O O O O',\n",
              "  'BACKGROUND : Glioblastoma is a malignant tumor that occurs in the cerebrum during adulthood .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'With current treatment regimens including combined surgery , radiation and chemotherapy , the average life expectancy of the patients is limited to approximately 1 year .'],\n",
              " ['O O O O B O O O O O O O O O O O O',\n",
              "  'Therefore , patients with glioblastoma sometimes have intracarotid injection of carcinostatics added to the treatment regimen .'],\n",
              " ['O O O O O O O O O O O O O O B I I I O O O O',\n",
              "  'Generally , carboplatin is said to have milder side effects than cisplatin , whose ocular and orbital toxicity are well known .'],\n",
              " ['O O O O O O O O B I I I O O O O O O O O O O O',\n",
              "  'However , we experienced a case of severe ocular and orbital toxicity after intracarotid injection of carboplatin , which is infrequently reported .'],\n",
              " ['O O O O O O O O O O O O O O O O O B O O O O O O',\n",
              "  'CASE : A 58 - year - old man received an intracarotid injection of carboplatin for recurrent glioblastomas in his left temporal lobe .'],\n",
              " ['O O O B I I I I I I I O O O O O O',\n",
              "  'He complained of pain and visual disturbance in the ipsilateral eye 30 h after the injection .'],\n",
              " ['O O O O O O O O B O O O',\n",
              "  'Various ocular symptoms and findings caused by carboplatin toxicity were seen .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O',\n",
              "  'RESULTS : He was treated with intravenous administration of corticosteroids and glycerin for 6 days after the injection .'],\n",
              " ['O O O O O O O O O O O O B O O B I O O O B O O B I O O O O O',\n",
              "  'Although the intraocular pressure elevation caused by secondary acute angle - closure glaucoma decreased and ocular pain diminished , inexorable papilledema and exudative retinal detachment continued for 3 weeks .'],\n",
              " ['O O O O O O O B I O B I O O O O O O O O O O O',\n",
              "  'Finally , 6 weeks later , diffuse chorioretinal atrophy with optic atrophy occurred and the vision in his left eye was lost .'],\n",
              " ['O O O O O O O O O O O O O O O O O B I O',\n",
              "  'CONCLUSION : When performing intracarotid injection of carboplatin , we must be aware of its potentially blinding ocular toxicity .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O',\n",
              "  'It is recommended that further studies and investigations are undertaken in the effort to minimize such severe side effects .'],\n",
              " ['B I O O O O', 'Visual hallucinations associated with zonisamide .'],\n",
              " ['O O O O O O O O O O O O O O B O',\n",
              "  'Zonisamide is a broad - spectrum antiepileptic drug used to treat various types of seizures .'],\n",
              " ['O B I O O O O O O O O O O O O O O O O O O O B I O O O O O O',\n",
              "  'Although visual hallucinations have not been reported as an adverse effect of this agent , we describe three patients who experienced complex visual hallucinations and altered mental status after zonisamide'],\n",
              " ['O O O O O O O O', 'treatment was begun or its dosage increased .'],\n",
              " ['O O O O O O O B O O O O O O O O O O O',\n",
              "  'All three had been diagnosed earlier with epilepsy , and their electroencephalogram ( EEG ) findings were abnormal .'],\n",
              " ['O O O B I O O O O O O O O O O O O O O O O O O',\n",
              "  'During monitoring , visual hallucinations did not correlate with EEG readings , nor did video recording capture any of the described events .'],\n",
              " ['O O O O O O B I O O O O',\n",
              "  'None of the patients had experienced visual hallucinations before this event .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'The only recent change in their treatment was the introduction or increased dosage of zonisamide .'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  'With either discontinuation or decreased dosage of the drug the symptoms disappeared and did not recur .'],\n",
              " ['O O O O O O O O O O O',\n",
              "  'Further observations and reports will help clarify this adverse effect .'],\n",
              " ['O O O O O O O O O O O O O O O O',\n",
              "  'Until then , clinicians need to be aware of this possible complication associated with zonisamide .'],\n",
              " ['O O B O O O O O B I O',\n",
              "  'Anti - epileptic drugs - induced de novo absence seizures .'],\n",
              " ['O O O O O O O O B I O O O O O O O',\n",
              "  'The authors present three patients with de novo absence epilepsy after administration of carbamazepine and vigabatrin .'],\n",
              " ['O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'Despite the underlying diseases , the prognosis for drug - induced de novo absence seizure is good because it subsides rapidly after discontinuing the use of the offending drugs .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'The gamma - aminobutyric acid - transmitted thalamocortical circuitry accounts for a major part of the underlying neurophysiology of the absence epilepsy .'],\n",
              " ['O O O O O O B I O O O O O O O O O O O O O O O',\n",
              "  'Because drug - induced de novo absence seizure is rare , pro - absence drugs can only be considered a promoting factor .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O B I O',\n",
              "  'The underlying epileptogenecity of the patients or the synergistic effects of the accompanying drugs is required to trigger the de novo absence seizure .'],\n",
              " ['O O O O O O O O O O O O O O O B O O O O O B O O O O O O O O',\n",
              "  'The possibility of drug - induced aggravation should be considered whenever an unexpected increase in seizure frequency and / or new seizure types appear following a change in drug treatment'],\n",
              " ['O', '.'],\n",
              " ['O O O O O O B I O O O O O O O O O O O O B O O O O O B I O',\n",
              "  'By understanding the underlying mechanism of absence epilepsy , we can avoid the inappropriate use of anticonvulsants in children with epilepsy and prevent drug - induced absence seizures .'],\n",
              " ['O O O B O B I O O O O',\n",
              "  'Prenatal dexamethasone programs hypertension and renal injury in the rat .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'Dexamethasone is frequently administered to the developing fetus to accelerate pulmonary development .'],\n",
              " ['O O O O O O O O O O O O O O O B I I I O B I O O O',\n",
              "  'The purpose of the present study was to determine if prenatal dexamethasone programmed a progressive increase in blood pressure and renal injury in rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Pregnant rats were given either vehicle or 2 daily intraperitoneal injections of dexamethasone ( 0 . 2 mg / kg body weight ) on gestational days 11 and 12 ,'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  '13 and 14 , 15 and 16 , 17 and 18 , or 19 and 20 .'],\n",
              " ['O O O O O O O O O O O O O O O B I I I O O O O O O O O O O O',\n",
              "  'Offspring of rats administered dexamethasone on days 15 and 16 gestation had a 20 % reduction in glomerular number compared with control at 6 to 9 months of age ('],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '22 527 + / - 509 versus 28 050 + / - 561 , P < 0 . 05 ) , which was comparable to the percent reduction in glomeruli'],\n",
              " ['O O O O O O O', 'measured at 3 weeks of age .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Six - to 9 - month old rats receiving prenatal dexamethasone on days 17 and 18 of gestation had a 17 % reduction in glomeruli ( 23 380 + /'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  '- 587 ) compared with control rats ( P < 0 . 05 ) .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O B I I O O O O',\n",
              "  'Male rats that received prenatal dexamethasone on days 15 and 16 , 17 and 18 , and 13 and 14 of gestation had elevated blood pressures at 6 months of'],\n",
              " ['O O O O O O O O O B I I I O',\n",
              "  'age ; the latter group did not have a reduction in glomerular number .'],\n",
              " ['O O O O O O O O O O O O O O O B O O O O',\n",
              "  'Adult rats given dexamethasone on days 15 and 16 of gestation had more glomeruli with glomerulosclerosis than control rats .'],\n",
              " ['O O O O O O O O O O O B I I I O B O O B O O O O O O O O',\n",
              "  'This study shows that prenatal dexamethasone in rats results in a reduction in glomerular number , glomerulosclerosis , and hypertension when administered at specific points during gestation .'],\n",
              " ['B O O O O O O O O O O O O O O O O O O O O O B I I I O O O O',\n",
              "  'Hypertension was observed in animals that had a reduction in glomeruli as well as in a group that did not have a reduction in glomerular number , suggesting that a'],\n",
              " ['B I I I O O O O O O O O O B O',\n",
              "  'reduction in glomerular number is not the sole cause for the development of hypertension .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Kidney function and morphology after short - term combination therapy with cyclosporine A , tacrolimus and sirolimus in the rat .'],\n",
              " ['O O O O O O O O O O O O O O O',\n",
              "  'BACKGROUND : Sirolimus ( SRL ) may supplement calcineurin inhibitors in clinical organ transplantation .'],\n",
              " ['O O B O O O O O O O O O O B O O O O O O O O O',\n",
              "  'These are nephrotoxic , but SRL seems to act differently displaying only minor nephrotoxic effects , although this question is still open .'],\n",
              " ['O O O O O O O O O O O O O O O O O O B O O O O',\n",
              "  'In a number of treatment protocols where SRL was combined with a calcineurin inhibitor indications of a synergistic nephrotoxic effect were described .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The aim of this study was to examine further the renal function , including morphological analysis of the kidneys of male Sprague - Dawley rats treated with either cyclosporine A'],\n",
              " ['O O O O O O O O O O O O O O O O O',\n",
              "  '( CsA ) , tacrolimus ( FK506 ) or SRL as monotherapies or in different combinations .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : For a period of 2 weeks , CsA 15 mg / kg / day ( given orally ) , FK506 3 . 0 mg / kg / day'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  '( given orally ) or SRL 0 . 4 mg / kg / day ( given intraperitoneally ) was administered once a day as these doses have earlier been found'],\n",
              " ['O O O O O O O O O O O O',\n",
              "  'to achieve a significant immunosuppressive effect in Sprague - Dawley rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  \"In the ' conscious catheterized rat ' model , the glomerular filtration rate ( GFR ) was measured as the clearance of Cr ( EDTA ) .\"],\n",
              " ['O O O O O O O O O O O O O O O O O O B O O B O O O O O O O O',\n",
              "  'The morphological analysis of the kidneys included a semi - quantitative scoring system analysing the degree of striped fibrosis , subcapsular fibrosis and the number of basophilic tubules , plus'],\n",
              " ['O O O O O O O O O B O O O O O O O O',\n",
              "  'an additional stereological analysis of the total grade of fibrosis in the cortex stained with Sirius Red .'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'RESULTS : CsA , FK506 and SRL all significantly decreased the GFR .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'A further deterioration was seen when CsA was combined with either FK506 or SRL , whereas the GFR remained unchanged in the group treated with FK506 plus SRL when compared'],\n",
              " ['O O O O O O O O O', 'with treatment with any of the single substances .'],\n",
              " ['O O O O O O O O',\n",
              "  'The morphological changes presented a similar pattern .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'The semi - quantitative scoring was significantly worst in the group treated with CsA plus SRL ( P < 0 . 001 compared with controls ) and the analysis of'],\n",
              " ['O O O O B O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'the total grade of fibrosis also showed the highest proportion in the same group and was significantly different from controls ( P < 0 . 02 ) .'],\n",
              " ['O O O O O O O O O O O O B O O O O O O O O O O O O',\n",
              "  'The FK506 plus SRL combination showed only a marginally higher degree of fibrosis as compared with controls ( P = 0 . 05 ) .'],\n",
              " ['O O O O O O O O B O O O O O O O O O O O O O O',\n",
              "  'CONCLUSION : This rat study demonstrated a synergistic nephrotoxic effect of CsA plus SRL , whereas FK506 plus SRL was better tolerated .'],\n",
              " ['O O O O O O O O O O O B I O O O O B O O O O O O O O O O O',\n",
              "  'Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin - induced cardiomyopathy rats , and their relationship with echocardiographic and histological findings .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O B I I O',\n",
              "  'BACKGROUND : Cardiac troponins I ( cTnI ) and T ( cTnT ) have been shown to be highly sensitive and specific markers of myocardial cell injury .'],\n",
              " ['O O O O O O O O O O O O O B I O O O O O O O O O O O B O O O',\n",
              "  'We investigated the diagnostic value of cTnI and cTnT for the diagnosis of myocardial damage in a rat model of doxorubicin ( DOX ) - induced cardiomyopathy , and we'],\n",
              " ['O O O O O O O O O O O O B I O O O O O O O O O O',\n",
              "  'examined the relationship between serial cTnI and cTnT with the development of cardiac disorders monitored by echocardiography and histological examinations in this model .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'METHODS : Thirty - five Wistar rats were given 1 . 5 mg / kg DOX , i . v . , weekly for up to 8 weeks for a'],\n",
              " ['O O O O O O O O O O', 'total cumulative dose of 12 mg / kg BW .'],\n",
              " ['O O O O O O O O O', 'Ten rats received saline as a control group .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'cTnI was measured with Access ( R ) ( ng / ml ) and a research immunoassay ( pg / ml ) , and compared with cTnT , CK -'],\n",
              " ['O O O O O', 'MB mass and CK .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'By using transthoracic echocardiography , anterior and posterior wall thickness , LV diameters and LV fractional shortening ( FS ) were measured in all rats before DOX or saline ,'],\n",
              " ['O O O O O O O O O O O O O',\n",
              "  'and at weeks 6 and 9 after treatment in all surviving rats .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'Histology was performed in DOX - rats at 6 and 9 weeks after the last DOX dose and in all controls .'],\n",
              " ['O O O O O O O O O O O B O O O O O O O',\n",
              "  'RESULTS : Eighteen of the DOX rats died prematurely of general toxicity during the 9 - week period .'],\n",
              " ['O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O',\n",
              "  'End - diastolic ( ED ) and end - systolic ( ES ) LV diameters / BW significantly increased , whereas LV FS was decreased after 9 weeks in the'],\n",
              " ...]"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 97
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "OfoLI0lKWeAW",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "# coding=utf-8\n",
        "# Copyright 2018 The Google AI Language Team Authors.\n",
        "#\n",
        "# Licensed under the Apache License, Version 2.0 (the \"License\");\n",
        "# you may not use this file except in compliance with the License.\n",
        "# You may obtain a copy of the License at\n",
        "#\n",
        "#     http://www.apache.org/licenses/LICENSE-2.0\n",
        "#\n",
        "# Unless required by applicable law or agreed to in writing, software\n",
        "# distributed under the License is distributed on an \"AS IS\" BASIS,\n",
        "# WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n",
        "# See the License for the specific language governing permissions and\n",
        "# limitations under the License.\n",
        "\"\"\"Tokenization classes.\"\"\"\n",
        "\n",
        "from __future__ import absolute_import\n",
        "from __future__ import division\n",
        "from __future__ import print_function\n",
        "\n",
        "import collections\n",
        "import re\n",
        "import unicodedata\n",
        "import six\n",
        "import tensorflow as tf\n",
        "\n",
        "\n",
        "def validate_case_matches_checkpoint(do_lower_case, init_checkpoint):\n",
        "  \"\"\"Checks whether the casing config is consistent with the checkpoint name.\"\"\"\n",
        "\n",
        "  # The casing has to be passed in by the user and there is no explicit check\n",
        "  # as to whether it matches the checkpoint. The casing information probably\n",
        "  # should have been stored in the bert_config.json file, but it's not, so\n",
        "  # we have to heuristically detect it to validate.\n",
        "\n",
        "  if not init_checkpoint:\n",
        "    return\n",
        "\n",
        "  m = re.match(\"^.*?([A-Za-z0-9_-]+)/bert_model.ckpt\", init_checkpoint)\n",
        "  if m is None:\n",
        "    return\n",
        "\n",
        "  model_name = m.group(1)\n",
        "\n",
        "  lower_models = [\n",
        "      \"uncased_L-24_H-1024_A-16\", \"uncased_L-12_H-768_A-12\",\n",
        "      \"multilingual_L-12_H-768_A-12\", \"chinese_L-12_H-768_A-12\"\n",
        "  ]\n",
        "\n",
        "  cased_models = [\n",
        "      \"cased_L-12_H-768_A-12\", \"cased_L-24_H-1024_A-16\",\n",
        "      \"multi_cased_L-12_H-768_A-12\"\n",
        "  ]\n",
        "\n",
        "  is_bad_config = False\n",
        "  if model_name in lower_models and not do_lower_case:\n",
        "    is_bad_config = True\n",
        "    actual_flag = \"False\"\n",
        "    case_name = \"lowercased\"\n",
        "    opposite_flag = \"True\"\n",
        "\n",
        "  if model_name in cased_models and do_lower_case:\n",
        "    is_bad_config = True\n",
        "    actual_flag = \"True\"\n",
        "    case_name = \"cased\"\n",
        "    opposite_flag = \"False\"\n",
        "\n",
        "  if is_bad_config:\n",
        "    raise ValueError(\n",
        "        \"You passed in `--do_lower_case=%s` with `--init_checkpoint=%s`. \"\n",
        "        \"However, `%s` seems to be a %s model, so you \"\n",
        "        \"should pass in `--do_lower_case=%s` so that the fine-tuning matches \"\n",
        "        \"how the model was pre-training. If this error is wrong, please \"\n",
        "        \"just comment out this check.\" % (actual_flag, init_checkpoint,\n",
        "                                          model_name, case_name, opposite_flag))\n",
        "\n",
        "\n",
        "def convert_to_unicode(text):\n",
        "  \"\"\"Converts `text` to Unicode (if it's not already), assuming utf-8 input.\"\"\"\n",
        "  if six.PY3:\n",
        "    if isinstance(text, str):\n",
        "      return text\n",
        "    elif isinstance(text, bytes):\n",
        "      return text.decode(\"utf-8\", \"ignore\")\n",
        "    else:\n",
        "      raise ValueError(\"Unsupported string type: %s\" % (type(text)))\n",
        "  elif six.PY2:\n",
        "    if isinstance(text, str):\n",
        "      return text.decode(\"utf-8\", \"ignore\")\n",
        "    elif isinstance(text, unicode):\n",
        "      return text\n",
        "    else:\n",
        "      raise ValueError(\"Unsupported string type: %s\" % (type(text)))\n",
        "  else:\n",
        "    raise ValueError(\"Not running on Python2 or Python 3?\")\n",
        "\n",
        "\n",
        "def printable_text(text):\n",
        "  \"\"\"Returns text encoded in a way suitable for print or `tf.logging`.\"\"\"\n",
        "\n",
        "  # These functions want `str` for both Python2 and Python3, but in one case\n",
        "  # it's a Unicode string and in the other it's a byte string.\n",
        "  if six.PY3:\n",
        "    if isinstance(text, str):\n",
        "      return text\n",
        "    elif isinstance(text, bytes):\n",
        "      return text.decode(\"utf-8\", \"ignore\")\n",
        "    else:\n",
        "      raise ValueError(\"Unsupported string type: %s\" % (type(text)))\n",
        "  elif six.PY2:\n",
        "    if isinstance(text, str):\n",
        "      return text\n",
        "    elif isinstance(text, unicode):\n",
        "      return text.encode(\"utf-8\")\n",
        "    else:\n",
        "      raise ValueError(\"Unsupported string type: %s\" % (type(text)))\n",
        "  else:\n",
        "    raise ValueError(\"Not running on Python2 or Python 3?\")\n",
        "\n",
        "\n",
        "def load_vocab(vocab_file):\n",
        "  \"\"\"Loads a vocabulary file into a dictionary.\"\"\"\n",
        "  vocab = collections.OrderedDict()\n",
        "  index = 0\n",
        "  with tf.gfile.GFile(vocab_file, \"r\") as reader:\n",
        "    while True:\n",
        "      token = convert_to_unicode(reader.readline())\n",
        "      if not token:\n",
        "        break\n",
        "      token = token.strip()\n",
        "      vocab[token] = index\n",
        "      index += 1\n",
        "  return vocab\n",
        "\n",
        "\n",
        "def convert_by_vocab(vocab, items):\n",
        "  \"\"\"Converts a sequence of [tokens|ids] using the vocab.\"\"\"\n",
        "  output = []\n",
        "  for item in items:\n",
        "    output.append(vocab[item])\n",
        "  return output\n",
        "\n",
        "\n",
        "def convert_tokens_to_ids(vocab, tokens):\n",
        "  return convert_by_vocab(vocab, tokens)\n",
        "\n",
        "\n",
        "def convert_ids_to_tokens(inv_vocab, ids):\n",
        "  return convert_by_vocab(inv_vocab, ids)\n",
        "\n",
        "\n",
        "def whitespace_tokenize(text):\n",
        "  \"\"\"Runs basic whitespace cleaning and splitting on a piece of text.\"\"\"\n",
        "  text = text.strip()\n",
        "  if not text:\n",
        "    return []\n",
        "  tokens = text.split()\n",
        "  return tokens\n",
        "\n",
        "\n",
        "class FullTokenizer(object):\n",
        "  \"\"\"Runs end-to-end tokenziation.\"\"\"\n",
        "\n",
        "  def __init__(self, vocab_file, do_lower_case=True):\n",
        "    self.vocab = load_vocab(vocab_file)\n",
        "    self.inv_vocab = {v: k for k, v in self.vocab.items()}\n",
        "    self.basic_tokenizer = BasicTokenizer(do_lower_case=do_lower_case)\n",
        "    self.wordpiece_tokenizer = WordpieceTokenizer(vocab=self.vocab)\n",
        "\n",
        "  def tokenize(self, text):\n",
        "    split_tokens = []\n",
        "    for token in self.basic_tokenizer.tokenize(text):\n",
        "      for sub_token in self.wordpiece_tokenizer.tokenize(token):\n",
        "        split_tokens.append(sub_token)\n",
        "\n",
        "    return split_tokens\n",
        "\n",
        "  def convert_tokens_to_ids(self, tokens):\n",
        "    return convert_by_vocab(self.vocab, tokens)\n",
        "\n",
        "  def convert_ids_to_tokens(self, ids):\n",
        "    return convert_by_vocab(self.inv_vocab, ids)\n",
        "\n",
        "\n",
        "class BasicTokenizer(object):\n",
        "  \"\"\"Runs basic tokenization (punctuation splitting, lower casing, etc.).\"\"\"\n",
        "\n",
        "  def __init__(self, do_lower_case=True):\n",
        "    \"\"\"Constructs a BasicTokenizer.\n",
        "\n",
        "    Args:\n",
        "      do_lower_case: Whether to lower case the input.\n",
        "    \"\"\"\n",
        "    self.do_lower_case = do_lower_case\n",
        "\n",
        "  def tokenize(self, text):\n",
        "    \"\"\"Tokenizes a piece of text.\"\"\"\n",
        "    text = convert_to_unicode(text)\n",
        "    text = self._clean_text(text)\n",
        "\n",
        "    # This was added on November 1st, 2018 for the multilingual and Chinese\n",
        "    # models. This is also applied to the English models now, but it doesn't\n",
        "    # matter since the English models were not trained on any Chinese data\n",
        "    # and generally don't have any Chinese data in them (there are Chinese\n",
        "    # characters in the vocabulary because Wikipedia does have some Chinese\n",
        "    # words in the English Wikipedia.).\n",
        "    text = self._tokenize_chinese_chars(text)\n",
        "\n",
        "    orig_tokens = whitespace_tokenize(text)\n",
        "    split_tokens = []\n",
        "    for token in orig_tokens:\n",
        "      if self.do_lower_case:\n",
        "        token = token.lower()\n",
        "        token = self._run_strip_accents(token)\n",
        "      split_tokens.extend(self._run_split_on_punc(token))\n",
        "\n",
        "    output_tokens = whitespace_tokenize(\" \".join(split_tokens))\n",
        "    return output_tokens\n",
        "\n",
        "  def _run_strip_accents(self, text):\n",
        "    \"\"\"Strips accents from a piece of text.\"\"\"\n",
        "    text = unicodedata.normalize(\"NFD\", text)\n",
        "    output = []\n",
        "    for char in text:\n",
        "      cat = unicodedata.category(char)\n",
        "      if cat == \"Mn\":\n",
        "        continue\n",
        "      output.append(char)\n",
        "    return \"\".join(output)\n",
        "\n",
        "  def _run_split_on_punc(self, text):\n",
        "    \"\"\"Splits punctuation on a piece of text.\"\"\"\n",
        "    chars = list(text)\n",
        "    i = 0\n",
        "    start_new_word = True\n",
        "    output = []\n",
        "    while i < len(chars):\n",
        "      char = chars[i]\n",
        "      if _is_punctuation(char):\n",
        "        output.append([char])\n",
        "        start_new_word = True\n",
        "      else:\n",
        "        if start_new_word:\n",
        "          output.append([])\n",
        "        start_new_word = False\n",
        "        output[-1].append(char)\n",
        "      i += 1\n",
        "\n",
        "    return [\"\".join(x) for x in output]\n",
        "\n",
        "  def _tokenize_chinese_chars(self, text):\n",
        "    \"\"\"Adds whitespace around any CJK character.\"\"\"\n",
        "    output = []\n",
        "    for char in text:\n",
        "      cp = ord(char)\n",
        "      if self._is_chinese_char(cp):\n",
        "        output.append(\" \")\n",
        "        output.append(char)\n",
        "        output.append(\" \")\n",
        "      else:\n",
        "        output.append(char)\n",
        "    return \"\".join(output)\n",
        "\n",
        "  def _is_chinese_char(self, cp):\n",
        "    \"\"\"Checks whether CP is the codepoint of a CJK character.\"\"\"\n",
        "    # This defines a \"chinese character\" as anything in the CJK Unicode block:\n",
        "    #   https://en.wikipedia.org/wiki/CJK_Unified_Ideographs_(Unicode_block)\n",
        "    #\n",
        "    # Note that the CJK Unicode block is NOT all Japanese and Korean characters,\n",
        "    # despite its name. The modern Korean Hangul alphabet is a different block,\n",
        "    # as is Japanese Hiragana and Katakana. Those alphabets are used to write\n",
        "    # space-separated words, so they are not treated specially and handled\n",
        "    # like the all of the other languages.\n",
        "    if ((cp >= 0x4E00 and cp <= 0x9FFF) or  #\n",
        "        (cp >= 0x3400 and cp <= 0x4DBF) or  #\n",
        "        (cp >= 0x20000 and cp <= 0x2A6DF) or  #\n",
        "        (cp >= 0x2A700 and cp <= 0x2B73F) or  #\n",
        "        (cp >= 0x2B740 and cp <= 0x2B81F) or  #\n",
        "        (cp >= 0x2B820 and cp <= 0x2CEAF) or\n",
        "        (cp >= 0xF900 and cp <= 0xFAFF) or  #\n",
        "        (cp >= 0x2F800 and cp <= 0x2FA1F)):  #\n",
        "      return True\n",
        "\n",
        "    return False\n",
        "\n",
        "  def _clean_text(self, text):\n",
        "    \"\"\"Performs invalid character removal and whitespace cleanup on text.\"\"\"\n",
        "    output = []\n",
        "    for char in text:\n",
        "      cp = ord(char)\n",
        "      if cp == 0 or cp == 0xfffd or _is_control(char):\n",
        "        continue\n",
        "      if _is_whitespace(char):\n",
        "        output.append(\" \")\n",
        "      else:\n",
        "        output.append(char)\n",
        "    return \"\".join(output)\n",
        "\n",
        "\n",
        "class WordpieceTokenizer(object):\n",
        "  \"\"\"Runs WordPiece tokenziation.\"\"\"\n",
        "\n",
        "  def __init__(self, vocab, unk_token=\"[UNK]\", max_input_chars_per_word=200):\n",
        "    self.vocab = vocab\n",
        "    self.unk_token = unk_token\n",
        "    self.max_input_chars_per_word = max_input_chars_per_word\n",
        "\n",
        "  def tokenize(self, text):\n",
        "    \"\"\"Tokenizes a piece of text into its word pieces.\n",
        "\n",
        "    This uses a greedy longest-match-first algorithm to perform tokenization\n",
        "    using the given vocabulary.\n",
        "\n",
        "    For example:\n",
        "      input = \"unaffable\"\n",
        "      output = [\"un\", \"##aff\", \"##able\"]\n",
        "\n",
        "    Args:\n",
        "      text: A single token or whitespace separated tokens. This should have\n",
        "        already been passed through `BasicTokenizer.\n",
        "\n",
        "    Returns:\n",
        "      A list of wordpiece tokens.\n",
        "    \"\"\"\n",
        "\n",
        "    text = convert_to_unicode(text)\n",
        "\n",
        "    output_tokens = []\n",
        "    for token in whitespace_tokenize(text):\n",
        "      chars = list(token)\n",
        "      if len(chars) > self.max_input_chars_per_word:\n",
        "        output_tokens.append(self.unk_token)\n",
        "        continue\n",
        "\n",
        "      is_bad = False\n",
        "      start = 0\n",
        "      sub_tokens = []\n",
        "      while start < len(chars):\n",
        "        end = len(chars)\n",
        "        cur_substr = None\n",
        "        while start < end:\n",
        "          substr = \"\".join(chars[start:end])\n",
        "          if start > 0:\n",
        "            substr = \"##\" + substr\n",
        "          if substr in self.vocab:\n",
        "            cur_substr = substr\n",
        "            break\n",
        "          end -= 1\n",
        "        if cur_substr is None:\n",
        "          is_bad = True\n",
        "          break\n",
        "        sub_tokens.append(cur_substr)\n",
        "        start = end\n",
        "\n",
        "      if is_bad:\n",
        "        output_tokens.append(self.unk_token)\n",
        "      else:\n",
        "        output_tokens.extend(sub_tokens)\n",
        "    return output_tokens\n",
        "\n",
        "\n",
        "def _is_whitespace(char):\n",
        "  \"\"\"Checks whether `chars` is a whitespace character.\"\"\"\n",
        "  # \\t, \\n, and \\r are technically contorl characters but we treat them\n",
        "  # as whitespace since they are generally considered as such.\n",
        "  if char == \" \" or char == \"\\t\" or char == \"\\n\" or char == \"\\r\":\n",
        "    return True\n",
        "  cat = unicodedata.category(char)\n",
        "  if cat == \"Zs\":\n",
        "    return True\n",
        "  return False\n",
        "\n",
        "\n",
        "def _is_control(char):\n",
        "  \"\"\"Checks whether `chars` is a control character.\"\"\"\n",
        "  # These are technically control characters but we count them as whitespace\n",
        "  # characters.\n",
        "  if char == \"\\t\" or char == \"\\n\" or char == \"\\r\":\n",
        "    return False\n",
        "  cat = unicodedata.category(char)\n",
        "  if cat.startswith(\"C\"):\n",
        "    return True\n",
        "  return False\n",
        "\n",
        "\n",
        "def _is_punctuation(char):\n",
        "  \"\"\"Checks whether `chars` is a punctuation character.\"\"\"\n",
        "  cp = ord(char)\n",
        "  # We treat all non-letter/number ASCII as punctuation.\n",
        "  # Characters such as \"^\", \"$\", and \"`\" are not in the Unicode\n",
        "  # Punctuation class but we treat them as punctuation anyways, for\n",
        "  # consistency.\n",
        "  if ((cp >= 33 and cp <= 47) or (cp >= 58 and cp <= 64) or\n",
        "      (cp >= 91 and cp <= 96) or (cp >= 123 and cp <= 126)):\n",
        "    return True\n",
        "  cat = unicodedata.category(char)\n",
        "  if cat.startswith(\"P\"):\n",
        "    return True\n",
        "  return False\n"
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "HqXvUyLdi3NW",
        "colab_type": "code",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        },
        "outputId": "6821e663-e21f-4877-9812-b02b9fad74f6"
      },
      "source": [
        "import os\n",
        "from google.colab import drive\n",
        "drive.mount('/content/gdrive/')\n",
        "\n",
        "path='gdrive/My Drive/HUB'\n"
      ],
      "execution_count": 101,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Drive already mounted at /content/gdrive/; to attempt to forcibly remount, call drive.mount(\"/content/gdrive/\", force_remount=True).\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "-fFTFfzjicLu",
        "colab_type": "code",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 34
        },
        "outputId": "3a29e4fb-4391-428f-c4ff-47cc31b24b56"
      },
      "source": [
        "#tokenizer를 class 선언처럼 하기 위한 test과정\n",
        "vocab=path+'/vocab.txt'\n",
        "\n",
        "wordtt= FullTokenizer(vocab)\n",
        "wordtt.tokenize(\"2003thseen six\")"
      ],
      "execution_count": 102,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['2003', '##ths', '##een', 'six']"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 102
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "WkUkVS9VicAK",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "def convert_single_example(ex_index, example, label_list, max_seq_length, tokenizer,mode):\n",
        "    vocab=path+'/vocab.txt' #구드path로 변경!\n",
        "    wordtt= FullTokenizer(vocab) #class형태로 선언\n",
        "    label_map = {}\n",
        "    for (i, label) in enumerate(label_list,1):\n",
        "        label_map[label] = i\n",
        "   # with open(os.path.join(FLAGS.output_dir, 'label2id.pkl'),'wb') as w:\n",
        "   #    pickle.dump(label_map,w)\n",
        "    textlist = example.text.split(' ')\n",
        "    labellist = example.label.split(' ')\n",
        "    tokens = []\n",
        "    labels = []\n",
        "    for i, word in enumerate(textlist):\n",
        "        token = wordtt.tokenize(word) #사용!! \n",
        "        tokens.extend(token)\n",
        "        label_1 = labellist[i]\n",
        "        for m in range(len(token)):\n",
        "            if m==0:\n",
        "                labels.append(label_1)\n",
        "            else:\n",
        "                labels.append(\"X\")\n",
        "    if len(tokens) >= max_seq_length - 1:\n",
        "        tokens = tokens[0:(max_seq_length - 2)]\n",
        "        labels = labels[0:(max_seq_length - 2)]\n",
        "    ntokens = []\n",
        "    segment_ids = []\n",
        "    label_ids = []\n",
        "    ntokens.append(\"[CLS]\")\n",
        "    segment_ids.append(0)\n",
        "    # append(\"O\") or append(\"[CLS]\") not sure!\n",
        "    label_ids.append(label_map[\"[CLS]\"])\n",
        "    for i, token in enumerate(tokens):\n",
        "        ntokens.append(token)\n",
        "        segment_ids.append(0)\n",
        "        label_ids.append(label_map[labels[i]])\n",
        "    ntokens.append(\"[SEP]\")\n",
        "    segment_ids.append(0)\n",
        "    # append(\"O\") or append(\"[SEP]\") not sure!\n",
        "    label_ids.append(label_map[\"[SEP]\"])\n",
        "    input_ids = tokenizer.convert_tokens_to_ids(ntokens)\n",
        "    input_mask = [1] * len(input_ids)\n",
        "    #label_mask = [1] * len(input_ids)\n",
        "    while len(input_ids) < max_seq_length:\n",
        "        input_ids.append(0)\n",
        "        input_mask.append(0)\n",
        "        segment_ids.append(0)\n",
        "        # we don't concerned about it!\n",
        "        label_ids.append(0)\n",
        "        ntokens.append(\"**NULL**\")\n",
        "        #label_mask.append(0)\n",
        "    # print(len(input_ids))\n",
        "    assert len(input_ids) == max_seq_length\n",
        "    assert len(input_mask) == max_seq_length\n",
        "    assert len(segment_ids) == max_seq_length\n",
        "    assert len(label_ids) == max_seq_length\n",
        "    #assert len(label_mask) == max_seq_length\n",
        "\n",
        "    if ex_index < 5:\n",
        "        tf.logging.info(\"*** Example ***\")\n",
        "        tf.logging.info(\"guid: %s\" % (example.guid))\n",
        "        tf.logging.info(\"tokens: %s\" % \" \".join(\n",
        "            [tokenization.printable_text(x) for x in tokens]))\n",
        "        tf.logging.info(\"input_ids: %s\" % \" \".join([str(x) for x in input_ids]))\n",
        "        tf.logging.info(\"input_mask: %s\" % \" \".join([str(x) for x in input_mask]))\n",
        "        tf.logging.info(\"segment_ids: %s\" % \" \".join([str(x) for x in segment_ids]))\n",
        "        tf.logging.info(\"label_ids: %s\" % \" \".join([str(x) for x in label_ids]))\n",
        "        #tf.logging.info(\"label_mask: %s\" % \" \".join([str(x) for x in label_mask]))\n",
        "\n",
        "    feature = InputFeatures(\n",
        "        input_ids=input_ids,\n",
        "        input_mask=input_mask,\n",
        "        segment_ids=segment_ids,\n",
        "        label_ids=label_ids,\n",
        "        #label_mask = label_mask\n",
        "    )\n",
        "    write_tokens(ntokens,mode)\n",
        "    return feature\n",
        "\n",
        "            "
      ],
      "execution_count": 0,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "bUv7zPnEjLjS",
        "colab_type": "code",
        "colab": {}
      },
      "source": [
        "convert_single_example()"
      ],
      "execution_count": 0,
      "outputs": []
    }
  ]
}